First Internet Bancorp
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
Contents
Item 1. FINANCIAL STATEMENTS
Condensed Consolidated Balance Sheets
(Amounts in thousands except share data)
| September 30, 2026 | December 31, 2025 | |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Cash and due from banks | $5,977 | $6,145 |
| Interest-bearing deposits | 646,297 | 450,632 |
| Total cash and cash equivalents | 652,274 | 456,777 |
| Securities available-for-sale, at fair value (amortized cost of $886,554 and $802,422 in 2026 and 2025, respectively) | 843,108 | 778,687 |
| Securities held-to-maturity, at amortized cost, net of allowance for credit losses of $0.1 million and $0.1 million in 2026 and 2025, respectively, (fair value of $228,694 and $238,815 in 2026 and 2025, respectively) | 255,934 | 250,609 |
| Loans held-for-sale | 34,855 | 108,608 |
| Loans | 3,863,984 | 3,746,728 |
| Allowance for credit losses - loans | (57,361) | (55,686) |
| Net loans | 3,806,623 | 3,691,042 |
| Accrued interest receivable | 28,565 | 27,909 |
| Federal Home Loan Bank of Indianapolis stock | 28,350 | 28,350 |
| Cash surrender value of bank-owned life insurance | 43,492 | 42,559 |
| Premises and equipment, net | 64,538 | 67,934 |
| Goodwill | 4,687 | 4,687 |
| Servicing asset, at fair value | 23,620 | 22,793 |
| Other real estate owned | 4,141 | 2,631 |
| Accrued income and other assets | 97,816 | 89,061 |
| Total assets | $5,888,003 | $5,571,647 |
| Liabilities and shareholders’ equity | ||
| Liabilities | ||
| Noninterest-bearing deposits | $159,051 | $146,879 |
| Interest-bearing deposits | 4,993,715 | 4,692,934 |
| Total deposits | 5,152,766 | 4,839,813 |
| Advances from Federal Home Loan Bank | 239,500 | 249,500 |
| Subordinated debt, net of unamortized debt issuance costs of $1,994 and $1,535 in 2026 and 2025, respectively | 123,506 | 105,465 |
| Accrued interest payable | 1,298 | 1,744 |
| Accrued expenses and other liabilities | 16,525 | 15,358 |
| Total liabilities | 5,533,595 | 5,211,880 |
| Commitments and contingencies | ||
| Shareholders’ equity | ||
| Preferred stock, no par value; 4,913,779 shares authorized; issued and outstanding - none | — | — |
| Voting common stock, no par value; 45,000,000 shares authorized; 8,733,574 and 8,686,994 shares issued and outstanding in 2026 and 2025, respectively | 188,065 | 186,577 |
| Nonvoting common stock, no par value; 86,221 shares authorized; issued and outstanding - none | — | — |
| Retained earnings | 201,399 | 193,320 |
| Accumulated other comprehensive loss | (35,056) | (20,130) |
| Total shareholders’ equity | 354,408 | 359,767 |
| Total liabilities and shareholders’ equity | $5,888,003 | $5,571,647 |
Condensed Consolidated Statements of Operations – Unaudited
(Amounts in thousands except share and per share data)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Interest income | ||||
| Loans | $62,656 | $68,958 | $184,188 | $198,305 |
| Securities – taxable | 10,772 | 8,614 | 30,216 | 26,139 |
| Securities – non-taxable | 621 | 652 | 1,904 | 1,967 |
| Other earning assets | 5,982 | 6,164 | 16,169 | 15,692 |
| Total interest income | 80,031 | 84,388 | 232,477 | 242,103 |
| Interest expense | ||||
| Deposits | 41,080 | 50,134 | 121,759 | 144,554 |
| Other borrowed funds | 4,209 | 3,902 | 11,939 | 14,111 |
| Total interest expense | 45,289 | 54,036 | 133,698 | 158,665 |
| Net interest income | 34,742 | 30,352 | 98,779 | 83,438 |
| Provision for credit losses - loans | 12,148 | 34,393 | 42,262 | 60,110 |
| Benefit for credit losses - debt securities held to maturity | (18) | — | (41) | (32) |
| (Benefit) provision for credit losses - off-balance sheet commitments | (501) | 396 | (872) | 252 |
| Net interest income (loss) after provision for credit losses | 23,113 | (4,437) | 57,430 | 23,108 |
| Noninterest income (loss) | ||||
| Service charges and fees | 1,391 | 369 | 3,347 | 912 |
| Loan servicing revenue | 2,824 | 2,055 | 8,533 | 6,017 |
| Loan servicing asset revaluation | (961) | (1,332) | (3,600) | (3,666) |
| Gain (loss) on sale of loans | 4,792 | (27,103) | 16,859 | (16,783) |
| Other | 1,153 | 1,364 | 4,263 | 4,857 |
| Total noninterest income (loss) | 9,199 | (24,647) | 29,402 | (8,663) |
| Noninterest expense | ||||
| Salaries and employee benefits | 14,761 | 14,384 | 41,567 | 38,358 |
| Marketing, advertising and promotion | 733 | 482 | 2,054 | 1,831 |
| Consulting and professional services | 960 | 979 | 3,412 | 3,143 |
| Data processing | 713 | 651 | 2,262 | 1,942 |
| Loan expenses | 2,392 | 1,850 | 6,680 | 4,901 |
| Premises and equipment | 3,654 | 3,572 | 11,048 | 9,968 |
| Deposit insurance premium | 1,660 | 1,584 | 4,758 | 4,546 |
| Other | 2,384 | 1,957 | 6,625 | 6,127 |
| Total noninterest expense | 27,257 | 25,459 | 78,406 | 70,816 |
| Income (loss) before income taxes | 5,055 | (54,543) | 8,426 | (56,371) |
| Income tax provision (benefit) | 236 | (12,950) | (1,269) | (15,914) |
| Net income (loss) | $4,819 | $(41,593) | $9,695 | $(40,457) |
| Income (loss) per share of common stock | ||||
| Basic | $0.55 | $(4.76) | $1.11 | $(4.63) |
| Diluted | $0.54 | $(4.76) | $1.10 | $(4.63) |
| Weighted-average number of common shares outstanding | ||||
| Basic | 8,762,827 | 8,742,052 | 8,750,511 | 8,730,519 |
| Diluted | 8,865,954 | 8,742,052 | 8,821,890 | 8,730,519 |
| Dividends declared per share | $0.06 | $0.06 | $0.18 | $0.18 |
Condensed Consolidated Statements of Comprehensive Loss – Unaudited
(Amounts in thousands)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Net income (loss) | $4,819 | $(41,593) | $9,695 | $(40,457) |
| Other comprehensive (loss) income | ||||
| Securities available-for-sale | ||||
| Net unrealized holding (losses) gains recorded within other comprehensive (loss) income before income tax | (18,215) | 4,454 | (19,711) | 12,114 |
| Income tax (benefit) provision | (4,190) | 1,027 | (4,533) | 2,788 |
| Net effect on other comprehensive (loss) income | (14,025) | 3,427 | (15,178) | 9,326 |
| Securities held-to-maturity | ||||
| Amortization of net unrealized holding losses on securities transferred from available-for-sale to held-to-maturity | 113 | 180 | 333 | 432 |
| Income tax provision | 27 | 44 | 81 | 109 |
| Net effect on other comprehensive income | 86 | 136 | 252 | 323 |
| Total other comprehensive (loss) income | (13,939) | 3,563 | (14,926) | 9,649 |
| Comprehensive loss | $(9,120) | $(38,030) | $(5,231) | $(30,808) |
Condensed Consolidated Statements of Changes in Shareholders’ Equity - Unaudited
Nine Months Ended September 30, 2026 and 2025
(Amounts in thousands except share and per share data)
| Voting andNonvotingCommonStock | RetainedEarnings | AccumulatedOtherComprehensiveLoss | TotalShareholders’Equity | |
|---|---|---|---|---|
| Balance, January 1, 2026 | $186,577 | $193,320 | $(20,130) | $359,767 |
| Net income | — | 9,695 | — | 9,695 |
| Other comprehensive loss | — | — | (14,926) | (14,926) |
| Dividends declared ($0.18 per share) | — | (1,616) | — | (1,616) |
| Recognition of the fair value of share-based compensation | 1,654 | — | — | 1,654 |
| Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units | 5 | — | — | 5 |
| Common stock redeemed for the net settlement of share-based awards | (171) | — | — | (171) |
| Balance, September 30, 2026 | $188,065 | $201,399 | $(35,056) | $354,408 |
| Balance, January 1, 2025 | $186,094 | $230,622 | $(32,653) | $384,063 |
| Net loss | — | (40,457) | — | (40,457) |
| Other comprehensive income | — | — | 9,649 | 9,649 |
| Dividends declared ($0.18 per share) | — | (1,601) | — | (1,601) |
| Recognition of the fair value of share-based compensation | 733 | — | — | 733 |
| Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units | 5 | — | — | 5 |
| Common stock redeemed for the net settlement of share-based awards | (224) | — | — | (224) |
| Balance, September 30, 2025 | $186,608 | $188,564 | $(23,004) | $352,168 |
Condensed Consolidated Statements of Changes in Shareholders’ Equity - Unaudited
Three Months Ended September 30, 2026 and 2025
(Amounts in thousands except per share data)
| Voting andNonvotingCommonStock | RetainedEarnings | AccumulatedOtherComprehensiveLoss | TotalShareholders’Equity | |
|---|---|---|---|---|
| Balance, July 1, 2026 | $187,545 | $197,119 | $(21,117) | $363,547 |
| Net income | — | 4,819 | — | 4,819 |
| Other comprehensive loss | — | — | (13,939) | (13,939) |
| Dividends declared ($0.06 per share) | — | (539) | — | (539) |
| Recognition of the fair value of share-based compensation | 515 | — | — | 515 |
| Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units | 5 | — | — | 5 |
| Balance, September 30, 2026 | $188,065 | $201,399 | $(35,056) | $354,408 |
| Balance, July 1, 2025 | $186,116 | $230,690 | $(26,567) | $390,239 |
| Net loss | — | (41,593) | — | (41,593) |
| Other comprehensive income | — | — | 3,563 | 3,563 |
| Dividends declared ($0.06 per share) | — | (533) | — | (533) |
| Recognition of the fair value of share-based compensation | 490 | — | — | 490 |
| Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units | 2 | — | — | 2 |
| Balance, September 30, 2025 | $186,608 | $188,564 | $(23,004) | $352,168 |
Condensed Consolidated Statements of Cash Flows – Unaudited
(Amounts in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Operating activities | ||
| Net income (loss) | $9,695 | $(40,457) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization | 5,706 | 5,230 |
| Increase in cash surrender value of bank-owned life insurance | (933) | (862) |
| Provision for credit losses | 41,349 | 60,330 |
| Share-based compensation expense | 1,654 | 733 |
| Loans originated for sale | (163,688) | (430,086) |
| Proceeds from sale of loans | 249,872 | 381,503 |
| (Gain) loss on loans sold | (16,859) | 16,783 |
| Loss (gain) on sale of other real estate owned | 15 | (19) |
| Gain on derivatives | — | (106) |
| Loan servicing asset revaluation | 3,600 | 3,666 |
| Net change in accrued income and other assets | (2,371) | (13,115) |
| Net change in accrued expenses and other liabilities | 1,197 | (3,874) |
| Net cash provided by (used in) operating activities | 129,237 | (20,274) |
| Investing activities | ||
| Net loan activity, excluding purchases | (141,986) | (295,966) |
| Proceeds from sale of other real estate owned | 1,162 | 547 |
| Maturities and calls of securities available-for-sale | 122,792 | 97,804 |
| Purchase of securities available-for-sale | (208,697) | (125,713) |
| Maturities and calls of securities held-to-maturity | 28,813 | 22,103 |
| Purchase of securities held-to-maturity | (33,844) | (33,629) |
| Purchase of premises and equipment | (364) | (940) |
| Loans purchased | (18,543) | (47,674) |
| Net proceeds from sale of portfolio loans | — | 799,297 |
| Other investing activities | (2,020) | (9,214) |
| Net cash (used in) provided by investing activities | (252,687) | 406,615 |
| Financing activities | ||
| Net increase (decrease) in deposits | 312,953 | (17,772) |
| Cash dividends paid | (1,568) | (1,571) |
| Retirement of subordinated debt | (2,000) | — |
| Net proceeds from issuance of subordinated debt | 19,774 | — |
| Proceeds from advances from Federal Home Loan Bank | — | 104,500 |
| Repayment of advances from Federal Home Loan Bank | (10,000) | (150,000) |
| Other, net | (212) | (247) |
| Net cash provided by (used in) financing activities | 318,947 | (65,090) |
| Net increase in cash and cash equivalents | 195,497 | 321,251 |
| Cash and cash equivalents, beginning of period | 456,777 | 466,410 |
| Cash and cash equivalents, end of period | $652,274 | $787,661 |
| Supplemental disclosures | ||
| Cash paid during the period for interest | 134,144 | 159,924 |
| Cash (received) paid during the period for taxes | (2,086) | 258 |
| Loans transferred to other real estate owned | 2,686 | 2,058 |
| Loans transferred to held-for-sale from portfolio | — | 863,766 |
| Cash dividends declared, paid in subsequent period | 524 | 523 |
Notes to Condensed Consolidated Financial Statements – Unaudited
(Table amounts in thousands except share and per share data)
Note 1: Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information or footnotes necessary for a complete presentation of financial condition, results of operations, changes in shareholders’ equity, or cash flows in accordance with GAAP. In our opinion, all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation have been included. The results of operations for the three and nine months ended September 30, 2026 are not necessarily indicative of the results expected for the year ending December 31, 2026 or any other period. The September 30, 2026 condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the First Internet Bancorp Annual Report on Form 10-K for the year ended December 31, 2025.
The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, or assumptions that could have a material effect on the carrying value of certain assets and liabilities. These estimates, judgments, and assumptions affect the amounts reported in the condensed consolidated financial statements and the disclosures provided. The Company utilizes processes that involve the use of significant estimates and the judgment of management in determining the amount of the Company’s allowance for credit losses (“ACL”) and changes in any of these could have a significant impact on the condensed consolidated financial statements.
The condensed consolidated financial statements include the accounts of First Internet Bancorp (the “Company”), its wholly owned subsidiary, First Internet Bank of Indiana (the “Bank”), and the Bank’sthree wholly owned subsidiaries, First Internet Public Finance Corp., JKH Realty Services, LLC and SPF15, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation.
The Company is subject to claims and lawsuits that arise primarily in the ordinary course of business. It is the opinion of management that the disposition or ultimate resolution of such claims and lawsuits will not have a material adverse effect on the consolidated financial position, results of operations, and cash flows of the Company.
Note 2: Earnings (Loss) Per Share
Earnings (loss) per share of common stock are based on the weighted-average number of basic shares and dilutive shares outstanding during the period.
The following is a reconciliation of the weighted-average common shares for the basic and diluted earnings (loss) per share computations for the three and nine months ended September 30, 2026 and 2025.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| (dollars in thousands, except share and per share data) | 2026 | 2025 | 2026 | 2025 |
| Basic earnings (loss) per share | ||||
| Net income (loss) | $4,819 | $(41,593) | $9,695 | $(40,457) |
| Weighted-average common shares | 8,762,827 | 8,742,052 | 8,750,511 | 8,730,519 |
| Basic earnings (loss) per common share | $0.55 | $(4.76) | $1.11 | $(4.63) |
| Diluted earnings (loss) per share | ||||
| Net income (loss) | $4,819 | $(41,593) | $9,695 | $(40,457) |
| Weighted-average common shares | 8,762,827 | 8,742,052 | 8,750,511 | 8,730,519 |
| Dilutive effect of equity compensation | 103,127 | — | 71,379 | — |
| Weighted-average common and incremental shares | 8,865,954 | 8,742,052 | 8,821,890 | 8,730,519 |
| Diluted earnings (loss) per common share 1 | $0.54 | $(4.76) | $1.10 | $(4.63) |
1 Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. There wereno antidilutive shares for the three months ended September 30, 2026. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 3,269 for the nine months ended September 30, 2026. Since the Company was in a loss position for the three and nine months ended September 30, 2025, basic net loss is the same as diluted net loss per share, as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive.
Note 3: Securities
The following tables summarize securities available-for-sale (“AFS”) and securities held-to-maturity (“HTM”) as of September 30, 2026 and December 31, 2025.
| Amortized Cost · Gross Unrealized · Fair Value | ||||
|---|---|---|---|---|
| (amounts in thousands) · Gains · Losses | ||||
| Securities available-for-sale | ||||
| U.S. Government-sponsored agencies | $50,426 | $430 | $(1,051) | $49,805 |
| Municipal securities | 56,941 | — | (6,356) | 50,585 |
| Agency mortgage-backed securities - residential 1 | 440,756 | 529 | (30,304) | 410,981 |
| Agency mortgage-backed securities - commercial | 56,468 | 66 | (1,442) | 55,092 |
| Private label mortgage-backed securities - residential | 121,790 | 1 | (2,934) | 118,857 |
| Asset-backed securities | 82,133 | 18 | (891) | 81,260 |
| Corporate securities | 78,040 | 178 | (1,690) | 76,528 |
| Total available-for-sale | $886,554 | $1,222 | $(44,668) | $843,108 |
| Amortized Cost · Gross Unrealized · Fair Value · Allowance for Credit Losses · Net Carrying Value | ||||||
|---|---|---|---|---|---|---|
| (amounts in thousands) · Gains · Losses | ||||||
| Securities held-to-maturity | ||||||
| Municipal securities | $9,831 | $— | $(966) | $8,865 | $(3) | $9,828 |
| Agency mortgage-backed securities - residential | 226,083 | 1 | (24,165) | 201,919 | — | 226,083 |
| Agency mortgage-backed securities - commercial | 5,580 | — | (1,222) | 4,358 | — | 5,580 |
| Corporate securities | 14,500 | — | (948) | 13,552 | (57) | 14,443 |
| Total held-to-maturity | $255,994 | $1 | $(27,301) | $228,694 | $(60) | $255,934 |
1 Includes $0.1 million of additional premium related to terminated interest rate swaps associated with agency mortgage-backed securities - residential as of September 30, 2026.
| Amortized Cost · Gross Unrealized · Fair Value | ||||
|---|---|---|---|---|
| (amounts in thousands) · Gains · Losses | ||||
| Securities available-for-sale | ||||
| U.S. Government-sponsored agencies | $64,298 | $480 | $(1,014) | $63,764 |
| Municipal securities | 64,777 | 17 | (1,408) | 63,386 |
| Agency mortgage-backed securities - residential 1 | 409,718 | 841 | (21,102) | 389,457 |
| Agency mortgage-backed securities - commercial | 59,112 | 202 | (837) | 58,477 |
| Private label mortgage-backed securities - residential | 124,264 | 234 | (825) | 123,673 |
| Asset-backed securities | 42,492 | 100 | (39) | 42,553 |
| Corporate securities | 37,761 | 346 | (730) | 37,377 |
| Total available-for-sale | $802,422 | $2,220 | $(25,955) | $778,687 |
| Amortized Cost · Gross Unrealized · Fair Value · Allowance for Credit Losses · Net Carrying Value | ||||||
|---|---|---|---|---|---|---|
| (amounts in thousands) · Gains · Losses | ||||||
| Securities held-to-maturity | ||||||
| Municipal securities | $11,009 | $1 | $(459) | $10,551 | $(3) | $11,006 |
| Agency mortgage-backed securities - residential | 213,530 | 1,834 | (11,649) | 203,715 | — | 213,530 |
| Agency mortgage-backed securities - commercial | 5,635 | — | (915) | 4,720 | — | 5,635 |
| Corporate securities | 20,536 | — | (707) | 19,829 | (98) | 20,438 |
| Total held-to-maturity | $250,710 | $1,835 | $(13,730) | $238,815 | $(101) | $250,609 |
1 Includes $0.2 million of additional premium related to terminated interest rate swaps associated with agency mortgage-backed securities - residential as of December 31, 2025.
Accrued interest receivable on AFS and HTM securities at September 30, 2026 was $3.4 million and $1.0 million, respectively, compared to $3.0 million and $1.1 million, respectively, at December 31, 2025, and is included in accrued interest receivable on the condensed consolidated balance sheet. The Company elected to exclude all accrued interest receivable from securities when estimating credit losses.
At September 30, 2026 and December 31, 2025, approximately 85% and 84%, respectively, of mortgage-backed securities (including both AFS and HTM) held by the Company are issued by U.S. government-sponsored entities and agencies. These securities are either explicitly or implicitly guaranteed by the U.S. government and have a long history of no credit losses; therefore, the Company did not record an ACL on these securities.
Additionally, the Company evaluated credit impairment for individual AFS securities that are in an unrealized loss position and determined that the unrealized losses are unrelated to credit quality and are primarily attributable to changes in interest rates and volatility in the financial markets. As the Company does not intend to sell the AFS securities that are in an unrealized loss position, and it is unlikely that it will be required to sell these securities before recovery of their amortized cost basis, the Company did not record an ACL on these securities.
The Company also evaluated its HTM securities that are in an unrealized loss position and considered issuer bond ratings, historical loss rates for bond ratings and economic forecasts. The ACL on HTM securities was $0.1 million at both September 30, 2026 and December 31, 2025.
The carrying value of securities at September 30, 2026 is shown below by their contractual maturity date. Actual maturities will differ because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
| Available-for-Sale | ||
|---|---|---|
| (amounts in thousands) | AmortizedCost | FairValue |
| Within one year | $4,025 | $3,997 |
| One to five years | 26,398 | 25,707 |
| Five to ten years | 114,992 | 108,869 |
| After ten years | 39,992 | 38,345 |
| 185,407 | 176,918 | |
| Agency mortgage-backed securities - residential | 440,756 | 410,981 |
| Agency mortgage-backed securities - commercial | 56,468 | 55,092 |
| Private label mortgage-backed securities - residential | 121,790 | 118,857 |
| Asset-backed securities | 82,133 | 81,260 |
| Total | $886,554 | $843,108 |
| Held-to-Maturity | ||
|---|---|---|
| (amounts in thousands) | AmortizedCost | FairValue |
| Within one year | $645 | $641 |
| One to five years | 10,645 | 10,434 |
| Five to ten years | 12,992 | 11,293 |
| After ten years | 49 | 49 |
| 24,331 | 22,417 | |
| Agency mortgage-backed securities - residential | 226,083 | 201,919 |
| Agency mortgage-backed securities - commercial | 5,580 | 4,358 |
| Total | $255,994 | $228,694 |
No AFS securities were sold during the three and nine months ended September 30, 2026 and September 30, 2025. As such, the Company didnot realize any gains or losses related to the sale of AFS securities during either time period.
Certain investments in debt securities are reported in the condensed consolidated financial statements at an amount less than their historical cost. The total fair value of these investments at September 30, 2026 and December 31, 2025 was $926.0 million and $611.2 million, which was approximately 84% and 59%, respectively, of the Company’s AFS and HTM securities portfolios. As of September 30, 2026, the Company’s security portfolio consisted of 646 positions, of which 564 were in an unrealized loss position. As of December 31, 2025, the Company’s security portfolio consisted of 618 positions, of which 395 were in an unrealized loss position. The unrealized losses are related to the categories noted below.
U. S. Government-Sponsored Agencies, Municipal Securities and Corporate Securities
The unrealized losses on the Company’s investments in securities issued by U.S. Government-sponsored agencies, municipal organizations and corporate entities were caused primarily by interest rate changes. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments. The Company does not intend to sell the investments, and it is not more likely than not that the Company will be required to sell the investments, before recovery of their amortized cost basis, which may be upon maturity.
Agency Mortgage-Backed, Private Label Mortgage-Backed Securities and Asset-Backed Securities
The unrealized losses on the Company’s investments in agency mortgage-backed, private label mortgage-backed securities and asset-backed securities were caused primarily by interest rate changes. The Company expects to recover the amortized cost basis over the terms of the securities. The Company does not intend to sell the investments, and it is not more likely than not that the Company will be required to sell the investments, before recovery of their amortized cost basis, which may be upon maturity.
The following tables show the securities portfolio’s gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at September 30, 2026 and December 31, 2025.
| Less Than 12 Months | 12 Months or Longer | Total | ||||
|---|---|---|---|---|---|---|
| (amounts in thousands) | FairValue | UnrealizedLosses | FairValue | UnrealizedLosses | FairValue | UnrealizedLosses |
| Securities available-for-sale | ||||||
| U.S. Government-sponsored agencies | $1,239 | $(7) | $19,895 | $(1,044) | $21,134 | $(1,051) |
| Municipal securities | 24,074 | (1,746) | 25,511 | (4,610) | 49,585 | (6,356) |
| Agency mortgage-backed securities - residential | 195,924 | (3,722) | 140,299 | (26,582) | 336,223 | (30,304) |
| Agency mortgage-backed securities - commercial | 13,889 | (383) | 23,051 | (1,059) | 36,940 | (1,442) |
| Private label mortgage-backed securities - residential | 105,729 | (1,962) | 12,349 | (972) | 118,078 | (2,934) |
| Asset-backed securities | 70,256 | (891) | — | — | 70,256 | (891) |
| Corporate securities | 51,150 | (1,115) | 14,425 | (575) | 65,575 | (1,690) |
| Total | $462,261 | $(9,826) | $235,530 | $(34,842) | $697,791 | $(44,668) |
| Less Than 12 Months | 12 Months or Longer | Total | ||||
|---|---|---|---|---|---|---|
| (amounts in thousands) | FairValue | UnrealizedLosses | FairValue | UnrealizedLosses | FairValue | UnrealizedLosses |
| Securities available-for-sale | ||||||
| U.S. Government-sponsored agencies | $3,600 | $(20) | $33,849 | $(994) | $37,449 | $(1,014) |
| Municipal securities | 2,301 | — | 42,515 | (1,408) | 44,816 | (1,408) |
| Agency mortgage-backed securities - residential | 67,177 | (190) | 186,453 | (20,912) | 253,630 | (21,102) |
| Agency mortgage-backed securities - commercial | 2,981 | (22) | 25,915 | (815) | 28,896 | (837) |
| Private label mortgage-backed securities - residential | 75,924 | (191) | 6,533 | (634) | 82,457 | (825) |
| Asset-backed securities | 21,413 | (39) | — | — | 21,413 | (39) |
| Corporate securities | 3,698 | (52) | 14,322 | (678) | 18,020 | (730) |
| Total | $177,094 | $(514) | $309,587 | $(25,441) | $486,681 | $(25,955) |
The following tables summarize ratings for the Company’s HTM portfolio as of September 30, 2026 and December 31, 2025.
| (amounts in thousands) | Municipal Securities | Mortgage-Backed Securities - Residential | Mortgage-Backed Securities - Commercial | Corporate Securities | Total |
|---|---|---|---|---|---|
| AAA equivalent - agency | $— | $226,083 | $5,580 | $— | $231,663 |
| Aa1/AA+ | 5,869 | — | — | — | 5,869 |
| Aa2/AA | 2,170 | — | — | — | 2,170 |
| Aa3/AA- | 1,792 | — | — | — | 1,792 |
| A3/A- | — | — | — | 5,000 | 5,000 |
| Baa1/BBB+ | — | — | — | 5,000 | 5,000 |
| Baa2/BBB | — | — | — | 2,000 | 2,000 |
| Baa3/BBB- | — | — | — | 2,500 | 2,500 |
| Total | $9,831 | $226,083 | $5,580 | $14,500 | $255,994 |
| (amounts in thousands) | Municipal Securities | Mortgage-Backed Securities - Residential | Mortgage-Backed Securities - Commercial | Corporate Securities | Total |
|---|---|---|---|---|---|
| AAA equivalent - agency | $— | $213,530 | $5,635 | $— | $219,165 |
| Aa1/AA+ | 7,046 | — | — | — | 7,046 |
| Aa2/AA | 2,170 | — | — | — | 2,170 |
| Aa3/AA- | 1,793 | — | — | — | 1,793 |
| A3/A- | — | — | — | 5,000 | 5,000 |
| Baa1/BBB+ | — | — | — | 5,000 | 5,000 |
| Baa2/BBB | — | — | — | 4,000 | 4,000 |
| Baa3/BBB- | — | — | — | 4,536 | 4,536 |
| Ba1/BB+ | — | — | — | 2,000 | 2,000 |
| Total | $11,009 | $213,530 | $5,635 | $20,536 | $250,710 |
Equity Investments
Equity investments, largely comprised of non-marketable equity investments, are generally accounted for under equity security accounting and are included within accrued income and other assets on the consolidated balance sheet. The Company’s non-marketable equity investments consist of limited partner interests in venture capital and Small Business Investment Company (“SBIC”) funds. After the initial commitment and over the course of the investment period, the Company will make capital contributions and receive a proportional share of profit and return of capital distributions as a result of fund performance until the funds wind down. While the partnership agreements allow the Company to remove the general partner, this right is not considered to be substantive as the general partner can only be removed for cause. All of these investments are generally non-redeemable and distributions are generally expected to be received through the liquidation of the underlying investments throughout the life of the investment fund. Investments may only be sold or transferred subject to the notice and approval provisions of the underlying investment agreements.
The following tables provide additional information related to equity investments accounted for under equity security accounting.
The carrying amount of each equity investment with a readily determinable fair value or net asset value at September 30, 2026 and December 31, 2025 is reflected in the following table:
| (amounts in thousands) | September 30, 2026 | December 31, 2025 |
|---|---|---|
| GenOpp Financial Fund LP | $3,176 | $2,876 |
| Total | $3,176 | $2,876 |
The carrying amount of the Company’s investments in non-marketable equity securities with no readily determinable fair value and amounts recognized in earnings on a cumulative basis at September 30, 2026 and December 31, 2025 is reflected in the following table:
| (amounts in thousands) | September 30, 2026 | December 31, 2025 |
|---|---|---|
| Carrying value1 | $38,553 | $38,611 |
| Carrying value adjustments | — | — |
| Impairment | — | — |
| Upward changes for observable prices | — | — |
| Downward changes for observable prices | — | — |
| Total | $38,553 | $38,611 |
1 Excludes $13.8 million and $14.6 million in unfunded commitments as of September 30, 2026 and December 31, 2025, respectively.
Variable Interest Entities
The above investments meet the criteria of a VIE. However, the Company is not the primary beneficiary of the entities as it does not have the power to direct the activities that most significantly impact the economic performance of the entities. The Company’s maximum exposure to loss from unconsolidated VIEs includes the value of the investment recorded on the Company’s consolidated balance sheets and unfunded commitment. The Company believes the potential for loss from these investments is remote, the maximum exposure for the affordable housing investment was determined by assuming a scenario where related tax credits were recaptured.
The following tables provides a summary of VIEs that the Company has not consolidated as September 30, 2026 and December 31, 2025:
| (amounts in thousands) | Carrying Amount | Maximum Exposure to Loss | Liability Recognized | Classification |
|---|---|---|---|---|
| Private equity and venture capital funds | $14,442 | $19,332 | $— | Other assets (1) |
| Pooled investment vehicle | 3,176 | 3,176 | — | Other assets (2) |
| SBIC | 7,292 | 13,000 | — | Other assets (3) |
| Affordable housing | 6,819 | 13,307 | — | Other assets (4) |
| Non-marketable and other equity investments | 10,000 | 10,000 | — | Other assets (5) |
| (amounts in thousands) | Carrying Amount | Maximum Exposure to Loss | Liability Recognized | Classification |
|---|---|---|---|---|
| Private equity and venture capital funds | $13,685 | $20,208 | $— | Other assets (6) |
| Pooled investment vehicle | 2,876 | 2,876 | — | Other assets (7) |
| SBIC | 7,292 | 13,000 | — | Other assets (8) |
| Affordable housing | 7,634 | 12,519 | — | Other assets (9) |
| Non-marketable and other equity investments | 10,000 | 10,000 | — | Other assets (10) |
(1) Maximum exposure to loss includes $14.4 million of current investments and $4.9 million in unfunded commitments.
(2) Maximum exposure to loss includes $3.2 million of current investments.
(3) Maximum exposure to loss includes $7.3 million of current investments and $5.7 million in unfunded commitments.
(4) Maximum exposure to loss includes $6.8 million of current investments, $3.2 million in unfunded commitments and a scenario in which related tax credits of $3.3 million are recaptured, totaling $13.3 million.
(5) Maximum exposure to loss includes $10.0 million of current investments.
(6) Maximum exposure to loss includes $13.7 million of current investments and $6.0 million in unfunded commitments.
(7) Maximum exposure to loss includes $2.9 million of current investments.
(8) Maximum exposure to loss includes $7.3 million of current investments and $5.7 million in unfunded commitments.
(9) Maximum exposure to loss includes $7.6 million of current investments, $2.4 million in unfunded commitments and a scenario in which related tax credits of $2.5 million are recaptured, totaling $12.5 million.
(10) Maximum exposure to loss includes $10.0 million of current investments.
Note 4: Loans
Loan balances as of September 30, 2026 and December 31, 2025 are summarized in the table below. Categories of loans include:
| (amounts in thousands) | September 30, 2026 | December 31, 2025 |
|---|---|---|
| Commercial loans | ||
| Commercial and industrial | $237,667 | $221,714 |
| Owner-occupied commercial real estate | 50,082 | 48,575 |
| Investor commercial real estate | 753,690 | 647,394 |
| Construction | 400,302 | 372,668 |
| Single tenant lease financing | 308,594 | 222,925 |
| Public finance | 430,381 | 442,234 |
| Healthcare finance | 112,406 | 139,469 |
| Small business lending 1 | 439,335 | 430,024 |
| Franchise finance | 330,626 | 417,045 |
| Total commercial loans | 3,063,083 | 2,942,048 |
| Consumer loans | ||
| Residential mortgage | 319,972 | 343,110 |
| Home equity | 16,186 | 14,725 |
| Other consumer loans | 446,307 | 425,458 |
| Total consumer loans | 782,465 | 783,293 |
| Total commercial and consumer loans | 3,845,548 | 3,725,341 |
| Net deferred loan origination costs, premiums and discounts on purchased loans, and other2 | 18,436 | 21,387 |
| Total loans | 3,863,984 | 3,746,728 |
| Allowance for credit losses | (57,361) | (55,686) |
| Net loans | $3,806,623 | $3,691,042 |
1 Balances include $60.0 million and $52.2 million that are guaranteed by the U.S. government as of September 30, 2026 and December 31, 2025, respectively.
2 Includes carrying value adjustment of $16.4 million and $19.1 million related to terminated interest rate swaps associated with public finance loans as of September 30, 2026 and December 31, 2025, respectively.
During the third quarter 2026, the Company purchased a portfolio of embedded finance loans which are included in the commercial and industrial loan category for approximately $16.3 million. Certain loans within the acquired portfolio were classified as purchased credit deteriorated (“PCD”); however, the PCD loans were not material to the Company’s overall loan portfolio or allowance for credit losses and therefore are not separately presented. The allowance associated with the PCD loans is separately identified in the allowance for credit losses rollforward because it was established through the initial gross-up of the acquired loans rather than through provision expense.
The general risk characteristics specific to each loan portfolio segment are as follows:
Commercial and Industrial: Commercial and industrial loans’ sources of repayment are primarily based on the identified cash flows of the borrower and secondarily on the underlying collateral provided by the borrower. The cash flows of borrowers, however, may not be as expected, and the collateral securing these loans may fluctuate in value. Loans are made for working capital, equipment purchases, or other purposes. Most commercial and industrial loans are secured by the assets being financed and may incorporate a personal guarantee. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States.
Additionally, certain specialized lending activities included within commercial and industrial include wealth advisory lending, equipment finance and embedded finance, which are conducted nationwide. Wealth advisory loans are typically made to experienced registered investment advisors to finance practice acquisitions or support the growth of an existing practice. Equipment finance loans primarily finance titled vehicles and essential-use transportation equipment. Embedded finance loans are made to small businesses for working capital purposes and are originated through programs with the Company’s fintech partners. The sources of repayment for these specialized lending activities are primarily based on the identified cash flows from operations of the borrower and related entities and secondarily on the assets being financed and underlying collateral provided by the borrower as well as a personal guarantee.
Owner-Occupied Commercial Real Estate: The primary source of repayment is the cash flow from the ongoing operations and activities conducted by the borrower, or an affiliate of the borrower, who owns the property. This portfolio segment is generally concentrated in the Midwest and Southwest regions of the United States and its loans are often secured by manufacturing and service facilities.
Investor Commercial Real Estate: These loans are made on a nationwide basis and are underwritten primarily based on the cash flow expected to be generated from the property and are secondarily supported by the value of the real estate. These loans typically incorporate a personal guarantee from the primary sponsor or sponsors. This portfolio segment generally involves larger loan amounts with repayment primarily dependent on the successful leasing and operation of the property securing the loan or the business conducted on the property securing the loan. Investor commercial real estate loans may be more adversely affected by changing economic conditions in the real estate markets, industry dynamics or the overall health of the local economy where the property is located. The properties securing the Company’s investor commercial real estate portfolio tend to be diverse in terms of property type. Management monitors and evaluates commercial real estate loans based on property financial performance, collateral value, guarantor strength, economic and industry conditions together with other risk grade criteria. As a general rule, the Company avoids financing special use projects unless other underwriting factors are present to mitigate these additional risks.
Construction: Construction loans are made on a nationwide basis and are secured by land and related improvements and are made to assist in the construction of new structures, which may include commercial (retail, industrial, office, and multi-family) properties, land development for residential properties or single family residential properties offered for sale by the builder. These loans generally finance a variety of project costs, including land, site preparation, architectural services, construction, closing and soft costs and interim financing needs. The cash flows of builders, while initially predictable, may fluctuate with market conditions, and the value of the collateral securing these loans may be subject to fluctuations based on general economic changes.
Single Tenant Lease Financing: These loans are made on a nationwide basis to owners of real estate subject to long-term lease arrangements with single tenant operators. The real estate is typically operated by regionally, nationally or globally branded businesses. The loans are underwritten based on the financial strength of the borrower, characteristics of the real estate, cash flows generated from the lease arrangements and the financial strength of the tenant. Similar to the other loan portfolio segments, management monitors and evaluates these loans based on borrower and tenant financial performance, collateral value, industry trends and other risk grade criteria.
Public Finance: These loans are made on a nationwide basis to governmental and not-for-profit entities to provide both tax-exempt and taxable loans for a variety of purposes including: short-term cash-flow needs; debt refinancing; economic development; quality of life projects; infrastructure improvements; renewable energy projects; and equipment financing. The primary sources of repayment for public finance loans include pledged revenue sources including but not limited to: general obligations; property taxes; income taxes; tax increment revenue; utility revenue; gaming revenues; sales tax; and pledged general revenue. Certain loans may also include an additional collateral pledge of mortgaged property or a security interest in financed equipment.
Healthcare Finance: These loans are made on a nationwide basis to healthcare providers, primarily dentists, for practice acquisition financing or refinancing that occasionally includes owner-occupied commercial real estate and equipment purchases. The sources of repayment are primarily based on the identified cash flows from operations of the borrower and related entities and secondarily on the underlying collateral provided by the borrower.
Small Business Lending: These loans are made on a nationwide basis to small businesses and generally carry a partial guaranty from the U.S. Small Business Administration (“SBA”) under its 7(a) loan program. We generally sell the government guaranteed portion of SBA loans into the secondary market while retaining the non-guaranteed portion of the loan and the servicing rights. Loans in the small business lending portfolio have sources of repayment that are primarily based on the identified cash flows of the borrower and secondarily on any underlying collateral provided by the borrower. Loans may, but do not always, have a collateral shortfall. For SBA loans where the guaranteed portion is retained, the SBA guaranty provides a tertiary source of repayment to the Bank in the event of borrower default. Cash flows of borrowers, however, may not be as expected and collateral securing these loans may fluctuate in value. Loans are made for a broad array of purposes including, but not limited to, providing operating cash flow, funding ownership changes, and facilitating equipment and commercial real estate purchases.
Franchise Finance: These loans are made on a nationwide basis with financing options for new franchise units, recapitalization, expansion, equipment and working capital. The sources of repayment are either based on identified cash flows from existing operations of the borrower or pro forma cash flow for new franchise locations.
Residential Mortgage: With respect to residential loans that are secured by 1-to-4 family residences and are generally owner occupied, the Company typically establishes a maximum loan-to-value ratio and requires private mortgage insurance if that ratio is exceeded. Repayment of these loans is primarily dependent on the financial circumstances of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Repayment can also be impacted by changes in residential property values. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.
Home Equity: Home equity loans and lines of credit are typically secured by a subordinate interest in 1-to-4 family residences. Repayment of these loans and lines of credit is primarily dependent on the financial circumstances of the borrowers and may be impacted by changes in unemployment levels and property values on residential properties, among other economic conditions in the market. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.
Other Consumer: These loans primarily consist of consumer loans and credit cards. Consumer loans may be secured by consumer assets such as horse trailers or recreational vehicles. Some consumer loans are unsecured, such as small installment loans, home improvement loans and certain lines of credit. Repayment of consumer loans is primarily dependent upon the personal income of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.
ACL Methodology
The ACL for loans represents management's estimate of all expected credit losses over the expected life of the Company’s existing loan portfolio. Management estimates the ACL balance using relevant available information about the collectability of cash flows, from internal and external sources, including historical information relating to past events, current conditions, and reasonable and supportable forecasts of future economic conditions. When the Company is unable to forecast future economic events, management may revert to historical information.
The Company's methodologies incorporate a one-year reasonable and supportable forecast period with a one-year straight line reversion to the long-term historical average for most segments.
The ACL methodology may also consider other adjustments to address changes in conditions, trends, and circumstances such as local industry changes that could have a significant impact on the risk profile of the loan portfolio and provide for adjustments that may not be reflected and/or captured in the historical loss data. These factors include: lending policies, imprecision in forecasting future economic conditions, loan profile, lending staff, problem loan trends, loan review, collateral, credit concentration, or other internal and external factors. The Company includes these as qualitative adjustments to the ACL which include, but are not limited to:
Changes in lending policies and procedures, including changes in underwriting standards and collections, charge-offs and recovery practices
Changes in international, national, regional and local economic conditions
Changes in the nature and volume of the portfolio and terms of loans
Changes in the experience, depth and ability of lending management
Changes in the volume and severity of past due loans and other similar conditions
Changes in the quality of the Company’s loan review system
Changes in the value of underlying collateral for collateral dependent loans
The existence and effect of any concentrations of credit and changes in the levels of such concentrations
The effect of other external factors (e.g. competition, legal and regulatory requirements) on the level of estimated credit losses
The ACL is measured on a collective or pool basis when similar risk characteristics exist. The Company segments its portfolio generally by Federal Financial Institutions Examination Council ("FFIEC") Call Report codes that align with its lines of business. Additional sub-segmentation has not been utilized to identify groups of loans with unique risk characteristics relative to the rest of the portfolio.
Loans that do not share similar risk characteristics are evaluated on an individual basis. These evaluations are typically performed on loans with a deteriorated internal risk rating. The ACL is determined based on several methods, including estimating the fair value of the underlying collateral or the present value of expected cash flows.
Modified Loans to Borrowers Experiencing Financial Difficulty
The Company may make modifications to certain loans in order to alleviate temporary difficulties in the borrower’s financial condition and/or constraints on the borrower’s ability to repay the loan, and to minimize potential losses to the Company. Modifications may include changes in the amortization terms of the loan, other-than-insignificant payment delays, reductions in interest rates, acceptance of interest only payments, and/or reductions to the outstanding loan balance. Such loans may be placed on nonaccrual status when there is doubt concerning the full repayment of principal and interest or the loan has been delinquent for a period of 90 days or more. These loans may be returned to accrual status when all contractual amounts past due have been brought current, and the borrower’s performance under the modified terms of the loan agreement and the ultimate collectability of all contractual amounts due under the modified terms is no longer in doubt. The Company typically measures the ACL on modified loans to borrowers experiencing financial difficulty on an individual basis when the loans are deemed to no longer share risk characteristics that are similar with other loans in the portfolio. The calculation of the ACL for these loans is based on a discounted cash flow approach for both those measured collectively and individually, unless the loan is deemed collateral dependent, which requires measurement of the ACL based on the estimated expected fair value of the underlying collateral, less costs to sell.
Provision for Credit Losses
A provision for estimated losses on loans is charged to income based upon management’s evaluation of the potential losses. Such an evaluation, which includes a review of all loans for which full repayment may not be reasonably assured, considers, among other matters, the estimated net realizable value of the underlying collateral, as applicable, economic conditions, loan loss experience, and other factors that are particularly susceptible to changes that could result in a material adjustment in the near term. While management attempts to use the best information available in making its evaluations, future ACL adjustments may be necessary if conditions change substantially from the assumptions used in making the evaluations.
Policy for Charging Off Loans
The Company’s policy is to charge off a loan at any point in time when it no longer can be considered a bankable asset, meaning collectible within the parameters of policy. Commercial loans are generally charged off when management determines they are uncollectible. Consumer loans are generally charged off when they reach a specified level of delinquency, unless they are well secured and in the process of collection.
The following tables present changes in the balance of the ACL during the three and nine months ended September 30, 2026 and 2025.
| (amounts in thousands) | Three Months Ended September 30, 2026 | |||||
|---|---|---|---|---|---|---|
| Allowance for credit losses: | Balance, Beginning of Period | Allowance on acquired PCD loans 1 | Provision (Credit) Charged to Expense | Charge-Offs | Recoveries | Balance, End of Period |
| Commercial and industrial | $1,860 | $141 | $2,469 | $(1,471) | $18 | $3,017 |
| Owner-occupied commercial real estate | 283 | — | (71) | — | — | 212 |
| Investor commercial real estate | 2,360 | — | (268) | — | — | 2,092 |
| Construction | 2,741 | — | (573) | — | — | 2,168 |
| Single tenant lease financing | 1,052 | — | (216) | — | — | 836 |
| Public finance | 384 | — | (19) | — | — | 365 |
| Healthcare finance | 324 | — | (43) | — | — | 281 |
| Small business lending | 25,135 | — | 6,531 | (3,943) | 261 | 27,984 |
| Franchise finance | 14,055 | — | 4,209 | (2,788) | 401 | 15,877 |
| Residential mortgage | 1,985 | — | 52 | (56) | 1 | 1,982 |
| Home equity | 32 | — | (1) | — | 2 | 33 |
| Other consumer loans | 2,885 | — | 78 | (519) | 70 | 2,514 |
| Total | $53,096 | $141 | $12,148 | $(8,777) | $753 | $57,361 |
1 The allowance established on acquired PCD loans was recorded through the acquisition-date gross-up of the acquired loans rather than through provision expense and was not material to the Company's total allowance for credit losses.
| (amounts in thousands) | Nine Months Ended September 30, 2026 | |||||
|---|---|---|---|---|---|---|
| Allowance for credit losses: | Balance, Beginning of Period | Allowance on acquired PCD loans 1 | Provision (Credit) Charged to Expense | Losses Charged Off | Recoveries | Balance, End of Period |
| Commercial and industrial | $1,942 | $141 | $2,818 | $(1,918) | $34 | $3,017 |
| Owner-occupied commercial real estate | 264 | — | (52) | — | — | 212 |
| Investor commercial real estate | 2,255 | — | (163) | — | — | 2,092 |
| Construction | 2,446 | — | (278) | — | — | 2,168 |
| Single tenant lease financing | 816 | — | 20 | — | — | 836 |
| Public finance | 411 | — | (46) | — | — | 365 |
| Healthcare finance | 605 | — | (286) | (38) | — | 281 |
| Small business lending | 27,796 | — | 17,711 | (18,380) | 857 | 27,984 |
| Franchise finance | 14,028 | — | 21,780 | (20,541) | 610 | 15,877 |
| Residential mortgage | 2,142 | — | (25) | (138) | 3 | 1,982 |
| Home equity | 38 | — | (9) | — | 4 | 33 |
| Other consumer loans | 2,943 | — | 792 | (1,430) | 209 | 2,514 |
| Total | $55,686 | $141 | $42,262 | $(42,445) | $1,717 | $57,361 |
1 The allowance established on acquired PCD loans was recorded through the acquisition-date gross-up of the acquired loans rather than through provision expense and was not material to the Company's total allowance for credit losses.
| (amounts in thousands) | Three Months Ended September 30, 2025 | ||||
|---|---|---|---|---|---|
| Allowance for credit losses: | Balance, Beginning of Period | (Credit) Provision Charged to Expense | Charge-Offs | Recoveries | Balance, End of Period |
| Commercial and industrial | $1,907 | $(40) | $(93) | $2 | $1,776 |
| Owner-occupied commercial real estate | 472 | (186) | — | — | 286 |
| Investor commercial real estate | 1,609 | 1,106 | — | — | 2,715 |
| Construction | 1,771 | 179 | — | — | 1,950 |
| Single tenant lease financing | 4,446 | (3,794) | — | — | 652 |
| Public finance | 522 | (93) | — | — | 429 |
| Healthcare finance | 1,199 | (482) | — | — | 717 |
| Small business lending | 13,722 | 29,634 | (15,883) | 635 | 28,108 |
| Franchise finance | 13,082 | 10,094 | (5,385) | 64 | 17,855 |
| Residential mortgage | 1,923 | 268 | (17) | — | 2,174 |
| Home equity | 92 | (54) | — | 2 | 40 |
| Other consumer loans | 5,772 | (2,239) | (374) | 62 | 3,221 |
| Total | $46,517 | $34,393 | $(21,752) | $765 | $59,923 |
| (amounts in thousands) | Nine Months Ended September 30, 2025 | ||||
|---|---|---|---|---|---|
| Allowance for loan losses: | Balance, Beginning of Period | Provision (Credit) Charged to Expense | Losses Charged Off | Recoveries | Balance, End of Period |
| Commercial and industrial | $1,265 | $598 | $(93) | $6 | $1,776 |
| Owner-occupied commercial real estate | 528 | (242) | — | — | 286 |
| Investor commercial real estate | 1,149 | 1,566 | — | — | 2,715 |
| Construction | 1,984 | (34) | — | — | 1,950 |
| Single tenant lease financing | 4,782 | (4,130) | — | — | 652 |
| Public finance | 703 | (274) | — | — | 429 |
| Healthcare finance | 1,412 | (695) | — | — | 717 |
| Small business lending | 16,161 | 42,542 | (31,403) | 808 | 28,108 |
| Franchise finance | 8,976 | 22,268 | (13,471) | 82 | 17,855 |
| Residential mortgage | 2,136 | 59 | (28) | 7 | 2,174 |
| Home equity | 106 | (71) | — | 5 | 40 |
| Other consumer loans | 5,567 | (1,477) | (1,046) | 177 | 3,221 |
| Total | $44,769 | $60,110 | $(46,041) | $1,085 | $59,923 |
Accrued interest receivable on loans totaled $23.1 million at both September 30, 2026 and December 31, 2025, respectively, and is excluded from the estimate of credit losses. The Company made the accounting policy election to not measure an ACL for accrued interest receivable. Accrued interest deemed uncollectible will be written off through interest income.
In addition to the ACL, the Company maintains a reserve for off-balance sheet commitments, classified in other liabilities. This reserve is at a level management believes to be sufficient to absorb losses arising from unfunded loan commitments. The adequacy of the reserve for unfunded commitments is determined quarterly based on methodology similar to the methodology for determining the ACL. The following tables detail activity in the (benefit) provision for credit losses on off-balance sheet commitments for the three and nine months ended September 30, 2026.
| (amounts in thousands) | BalanceJune 30, 2026 | (Benefit) Provision for Credit Losses | BalanceSeptember 30, 2026 |
|---|---|---|---|
| Off-balance sheet commitments | |||
| Commercial loans | |||
| Commercial and industrial | $191 | $(2) | $189 |
| Investor commercial real estate | 46 | (10) | 36 |
| Construction | 1,922 | (495) | 1,427 |
| Single tenant lease financing | 2 | (2) | — |
| Small business lending | 53 | 8 | 61 |
| Total commercial loans | 2,214 | (501) | 1,713 |
| Total allowance for off-balance sheet commitments | $2,214 | $(501) | $1,713 |
| (amounts in thousands) | Balance December 31, 2025 | (Benefit) Provision for Credit Losses | BalanceSeptember 30, 2026 |
|---|---|---|---|
| Off-balance sheet commitments | |||
| Commercial loans | |||
| Commercial and industrial | $177 | $12 | $189 |
| Investor commercial real estate | 36 | — | 36 |
| Construction | 2,259 | (832) | 1,427 |
| Single tenant lease financing | 1 | (1) | — |
| Small business lending | 112 | (51) | 61 |
| Total commercial loans | 2,585 | (872) | 1,713 |
| Total allowance for off-balance sheet commitments | $2,585 | $(872) | $1,713 |
The following tables detail activity in the (benefit) provision for credit losses on off-balance sheet commitments for the three and nine months ended September 30, 2025.
| (amounts in thousands) | Balance June 30, 2025 | (Benefit) Provision for Credit Losses | BalanceSeptember 30, 2025 |
|---|---|---|---|
| Off-balance sheet commitments | |||
| Commercial loans | |||
| Commercial and industrial | $199 | $(4) | $195 |
| Investor commercial real estate | 33 | 24 | 57 |
| Construction | 1,757 | 291 | 2,048 |
| Single tenant lease financing | 5 | (4) | 1 |
| Small business lending | 1 | 90 | 91 |
| Total commercial loans | 1,995 | 397 | 2,392 |
| Consumer loans | |||
| Residential mortgage | 1 | (1) | — |
| Total consumer loans | 1 | (1) | — |
| Total allowance for off-balance sheet commitments | $1,996 | $396 | $2,392 |
| (amounts in thousands) | Balance December 31, 2024 | (Benefit) Provision for Credit Losses | BalanceSeptember 30, 2025 |
|---|---|---|---|
| Off-balance sheet commitments | |||
| Commercial loans | |||
| Commercial and industrial | $233 | $(38) | $195 |
| Owner-occupied commercial real estate | 11 | (11) | — |
| Investor commercial real estate | 1 | 56 | 57 |
| Construction | 1,568 | 480 | 2,048 |
| Single tenant lease financing | 19 | (18) | 1 |
| Small business lending | 263 | (172) | 91 |
| Total commercial loans | 2,095 | 297 | 2,392 |
| Consumer loans | |||
| Residential mortgage | 1 | (1) | — |
| Home equity | 35 | (35) | — |
| Other consumer loans | 9 | (9) | — |
| Total consumer loans | 45 | (45) | — |
| Total allowance for off-balance sheet commitments | $2,140 | $252 | $2,392 |
The Company utilizes a risk grading matrix to assign a risk grade to each of its commercial loans, which are evaluated annually. A description of the general characteristics of the risk grades is as follows:
“Pass” - Higher quality loans that do not fit any of the other categories described below.
“Special Mention” - Loans that possess some potential credit deficiency or weakness, which deserve close attention.
“Substandard” - Loans that possess a defined weakness or weaknesses that jeopardize the liquidation of the debt. Loans characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Loans that are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any.
“Doubtful” - Such loans have been placed on nonaccrual status and may be heavily dependent upon collateral possessing a value that is difficult to determine or based upon some near-term event that lacks clear certainty. These loans have all of the weaknesses of those classified as Substandard; however, based on existing conditions, these weaknesses make full collection of the principal balance highly improbable.
The Company does not risk grade its consumer loans. It classifies them as either performing or nonperforming. Below is a description of those classifications:
“Performing” - Loans that are accruing and full collection of principal and interest is expected.
“Nonperforming” - Loans that are 90 days delinquent or for which the full collection of principal and interest may be in doubt.
The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios by loan class and by year of origination for the years indicated based on rating category and payment activity as of September 30, 2026 and December 31, 2025.
| September 30, 2026 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Term Loans (amortized cost basis by origination year) · Revolving loans amortized cost basis · Revolving loans converted to term | |||||||||
| (amounts in thousands) · 2026 · 2025 · 2024 · 2023 · 2022 · Prior · Total | |||||||||
| Commercial and industrial | |||||||||
| Pass | $68,419 | $81,521 | $13,599 | $4,715 | $6,779 | $13,823 | $32,240 | $— | $221,096 |
| Special Mention | 53 | 487 | 239 | — | 578 | 4,228 | 10,071 | — | 15,656 |
| Substandard | — | 559 | 238 | 118 | — | — | — | — | 915 |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total commercial and industrial | 68,472 | 82,567 | 14,076 | 4,833 | 7,357 | 18,051 | 42,311 | — | 237,667 |
| Year-to-date gross charge-offs | 165 | 1,621 | 99 | — | — | 33 | — | — | 1,918 |
| Owner-occupied commercial real estate | |||||||||
| Pass | 6,701 | 4,022 | 6,001 | 1,017 | 5,027 | 17,192 | — | — | 39,960 |
| Special Mention | — | — | — | — | — | 8,494 | — | — | 8,494 |
| Substandard | — | — | — | — | — | 1,628 | — | — | 1,628 |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total owner-occupied commercial real estate | 6,701 | 4,022 | 6,001 | 1,017 | 5,027 | 27,314 | — | — | 50,082 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| Investor commercial real estate | |||||||||
| Pass | 99,022 | 66,962 | 72,350 | 210,045 | 139,748 | 60,779 | — | — | 648,906 |
| Special Mention | — | — | — | 64,869 | 36,188 | 3,727 | — | — | 104,784 |
| Substandard | — | — | — | — | — | — | — | — | — |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total investor commercial real estate | 99,022 | 66,962 | 72,350 | 274,914 | 175,936 | 64,506 | — | — | 753,690 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| Construction | |||||||||
| Pass | 23,037 | 181,523 | 141,211 | 28,614 | 1,876 | 1,400 | 1,166 | — | 378,827 |
| Special Mention | — | — | — | — | 21,475 | — | — | — | 21,475 |
| Substandard | — | — | — | — | — | — | — | — | — |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total construction | 23,037 | 181,523 | 141,211 | 28,614 | 23,351 | 1,400 | 1,166 | — | 400,302 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| Single tenant lease financing | |||||||||
| Pass | 107,538 | 141,145 | 1,633 | 995 | 10,194 | 23,057 | — | — | 284,562 |
| Special Mention | — | 1,164 | — | — | 17,178 | 5,690 | — | — | 24,032 |
| Substandard | — | — | — | — | — | — | — | — | — |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total single tenant lease financing | 107,538 | 142,309 | 1,633 | 995 | 27,372 | 28,747 | — | — | 308,594 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| Public finance | |||||||||
| Pass | 37,358 | 33,100 | 6,502 | — | 4,857 | 347,609 | — | — | 429,426 |
| Special Mention | — | — | — | — | — | 955 | — | — | 955 |
| Substandard | — | — | — | — | — | — | — | — | — |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total public finance | 37,358 | 33,100 | 6,502 | — | 4,857 | 348,564 | — | — | 430,381 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| September 30, 2026 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Term Loans (amortized cost basis by origination year) · Revolving loans amortized cost basis · Revolving loans converted to term | |||||||||
| (amounts in thousands) · 2026 · 2025 · 2024 · 2023 · 2022 · Prior · Total | |||||||||
| Healthcare finance | |||||||||
| Pass | 252 | — | — | — | — | 111,332 | — | — | 111,584 |
| Special Mention | — | — | — | — | — | 692 | — | — | 692 |
| Substandard | — | — | — | — | — | 130 | — | — | 130 |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total healthcare finance | 252 | — | — | — | — | 112,154 | — | — | 112,406 |
| Year-to-date gross charge-offs | — | — | — | — | — | 38 | — | — | 38 |
| Small business lending | |||||||||
| Pass | 49,103 | 132,569 | 86,342 | 53,720 | 18,108 | 15,264 | 34,823 | — | 389,929 |
| Special Mention | 84 | 1,585 | 4,309 | 4,523 | 470 | 1,205 | 2,082 | — | 14,258 |
| Substandard | 6 | 8,593 | 9,537 | 7,307 | 1,583 | 974 | 7,148 | — | 35,148 |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total small business lending | 49,193 | 142,747 | 100,188 | 65,550 | 20,161 | 17,443 | 44,053 | — | 439,335 |
| Year-to-date gross charge-offs | 567 | 4,727 | 7,091 | 5,564 | 112 | 319 | — | — | 18,380 |
| Franchise finance | |||||||||
| Pass | — | 647 | 47,687 | 128,086 | 87,300 | 16,202 | — | — | 279,922 |
| Special Mention | 93 | 465 | 615 | 7,866 | 9,017 | — | — | — | 18,056 |
| Substandard | — | — | — | 13,479 | 14,518 | 3,851 | — | — | 31,848 |
| Doubtful | — | — | — | 800 | — | — | — | — | 800 |
| Total franchise finance | 93 | 1,112 | 48,302 | 150,231 | 110,835 | 20,053 | — | — | 330,626 |
| Year-to-date gross charge-offs | — | — | 2,082 | 4,889 | 4,883 | 8,687 | — | — | 20,541 |
| Consumer loans | |||||||||
| Residential mortgage | |||||||||
| Performing | 1,275 | 5,490 | 6,109 | 9,891 | 149,508 | 141,916 | — | — | 314,189 |
| Nonperforming | — | — | — | 138 | 3,708 | 1,937 | — | — | 5,783 |
| Total residential mortgage | 1,275 | 5,490 | 6,109 | 10,029 | 153,216 | 143,853 | — | — | 319,972 |
| Year-to-date gross charge-offs | — | — | — | — | 86 | 52 | — | — | 138 |
| Home equity | |||||||||
| Performing | 2,800 | — | — | 499 | 701 | 724 | 10,178 | 1,284 | 16,186 |
| Nonperforming | — | — | — | — | — | — | — | — | — |
| Total home equity | 2,800 | — | — | 499 | 701 | 724 | 10,178 | 1,284 | 16,186 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| Other consumer loans | |||||||||
| Performing | 89,903 | 86,974 | 72,084 | 63,851 | 61,433 | 71,202 | 731 | — | 446,178 |
| Nonperforming | — | 57 | 34 | — | 32 | 6 | — | — | 129 |
| Total other consumer loans | 89,903 | 87,031 | 72,118 | 63,851 | 61,465 | 71,208 | 731 | — | 446,307 |
| Year-to-date gross charge-offs | 62 | 217 | 204 | 416 | 176 | 355 | — | — | 1,430 |
| Total Loans | $485,644 | $746,863 | $468,490 | $600,533 | $590,278 | $854,017 | $98,439 | $1,284 | $3,845,548 |
| Total year-to-date gross charge-offs | $794 | $6,565 | $9,476 | $10,869 | $5,257 | $9,484 | $— | $— | $42,445 |
| December 31, 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Term Loans (amortized cost basis by origination year) · Revolving loans amortized cost basis · Revolving loans converted to term | |||||||||
| (amounts in thousands) · 2025 · 2024 · 2023 · 2022 · 2021 · Prior · Total | |||||||||
| Commercial and industrial | |||||||||
| Pass | $91,592 | $18,608 | $6,984 | $10,450 | $530 | $14,152 | $60,071 | $— | $202,387 |
| Special Mention | 177 | 256 | — | 4,746 | 4,237 | — | 9,671 | — | 19,087 |
| Substandard | 64 | 38 | 138 | — | — | — | — | — | 240 |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total commercial and industrial | 91,833 | 18,902 | 7,122 | 15,196 | 4,767 | 14,152 | 69,742 | — | 221,714 |
| Year-to-date gross charge-offs | 94 | 59 | — | — | — | — | — | — | 153 |
| Owner-occupied commercial real estate | |||||||||
| Pass | 4,159 | 6,202 | 1,421 | 5,174 | 4,155 | 15,966 | — | — | 37,077 |
| Special Mention | — | — | — | — | 852 | 8,991 | — | — | 9,843 |
| Substandard | — | — | — | — | — | 1,655 | — | — | 1,655 |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total owner-occupied commercial real estate | 4,159 | 6,202 | 1,421 | 5,174 | 5,007 | 26,612 | — | — | 48,575 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| Investor commercial real estate | |||||||||
| Pass | 61,333 | 80,798 | 195,528 | 179,155 | 91,708 | 35,141 | — | — | 643,663 |
| Special Mention | — | — | — | — | — | 3,731 | — | — | 3,731 |
| Substandard | — | — | — | — | — | — | — | — | — |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total investor commercial real estate | 61,333 | 80,798 | 195,528 | 179,155 | 91,708 | 38,872 | — | — | 647,394 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| Construction | |||||||||
| Pass | 65,190 | 147,941 | 132,835 | 23,114 | — | 2,042 | 1,546 | — | 372,668 |
| Special Mention | — | — | — | — | — | — | — | — | — |
| Substandard | — | — | — | — | — | — | — | — | — |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total construction | 65,190 | 147,941 | 132,835 | 23,114 | — | 2,042 | 1,546 | — | 372,668 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| Single tenant lease financing | |||||||||
| Pass | 144,764 | 1,370 | 1,007 | 10,377 | 2,021 | 29,524 | — | — | 189,063 |
| Special Mention | — | — | — | 18,628 | 4,168 | 9,401 | — | — | 32,197 |
| Substandard | — | — | — | — | — | 1,665 | — | — | 1,665 |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total single tenant lease financing | 144,764 | 1,370 | 1,007 | 29,005 | 6,189 | 40,590 | — | — | 222,925 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| Public finance | |||||||||
| Pass | 44,077 | 11,119 | — | 5,301 | 10,385 | 369,442 | — | — | 440,324 |
| Special Mention | — | — | — | — | — | 1,910 | — | — | 1,910 |
| Substandard | — | — | — | — | — | — | — | — | — |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total public finance | 44,077 | 11,119 | — | 5,301 | 10,385 | 371,352 | — | — | 442,234 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| December 31, 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Term Loans (amortized cost basis by origination year) · Revolving loans amortized cost basis · Revolving loans converted to term | |||||||||
| (amounts in thousands) · 2025 · 2024 · 2023 · 2022 · 2021 · Prior · Total | |||||||||
| Healthcare finance | |||||||||
| Pass | — | — | — | — | 7,317 | 128,623 | — | — | 135,940 |
| Special Mention | — | — | — | — | — | 933 | — | — | 933 |
| Substandard | — | — | — | — | — | 2,596 | — | — | 2,596 |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total healthcare finance | — | — | — | — | 7,317 | 132,152 | — | — | 139,469 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| Small business lending | |||||||||
| Pass | 152,566 | 103,270 | 62,754 | 21,651 | 7,851 | 13,779 | 27,048 | — | 388,919 |
| Special Mention | — | 7,519 | 5,276 | 514 | — | 1,475 | 1,953 | — | 16,737 |
| Substandard | — | 5,838 | 11,637 | 1,315 | 270 | 1,416 | 3,892 | — | 24,368 |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total small business lending | 152,566 | 116,627 | 79,667 | 23,480 | 8,121 | 16,670 | 32,893 | — | 430,024 |
| Year-to-date gross charge-offs | 400 | 16,668 | 17,755 | 2,821 | 1,087 | 919 | — | — | 39,650 |
| Franchise finance | |||||||||
| Pass | 718 | 56,732 | 172,080 | 120,012 | 29,064 | — | — | — | 378,606 |
| Special Mention | 510 | 628 | 3,351 | 6,972 | — | — | — | — | 11,461 |
| Substandard | — | 1,281 | 6,831 | 10,877 | 7,989 | — | — | — | 26,978 |
| Doubtful | — | — | — | — | — | — | — | — | — |
| Total franchise finance | 1,228 | 58,641 | 182,262 | 137,861 | 37,053 | — | — | — | 417,045 |
| Year-to-date gross charge-offs | — | 370 | 7,664 | 9,576 | 4,144 | — | — | — | 21,754 |
| Consumer loans | |||||||||
| Residential mortgage | |||||||||
| Performing | 4,770 | 6,271 | 10,901 | 163,760 | 78,631 | 73,883 | — | — | 338,216 |
| Nonperforming | — | — | — | 2,721 | 597 | 1,576 | — | — | 4,894 |
| Total residential mortgage | 4,770 | 6,271 | 10,901 | 166,481 | 79,228 | 75,459 | — | — | 343,110 |
| Year-to-date gross charge-offs | — | — | — | 75 | — | — | — | — | 75 |
| Home equity | |||||||||
| Performing | — | — | 628 | 1,009 | 187 | 761 | 11,330 | 810 | 14,725 |
| Nonperforming | — | — | — | — | — | — | — | — | — |
| Total home equity | — | — | 628 | 1,009 | 187 | 761 | 11,330 | 810 | 14,725 |
| Year-to-date gross charge-offs | — | — | — | — | — | — | — | — | — |
| Other consumer loans | |||||||||
| Performing | 98,688 | 85,148 | 77,999 | 72,978 | 26,284 | 63,224 | 903 | — | 425,224 |
| Nonperforming | — | 96 | 84 | 9 | 34 | 11 | — | — | 234 |
| Total other consumer loans | 98,688 | 85,244 | 78,083 | 72,987 | 26,318 | 63,235 | 903 | — | 425,458 |
| Year-to-date gross charge-offs | 79 | 279 | 491 | 189 | 31 | 388 | — | — | 1,457 |
| Total Loans | $668,608 | $533,115 | $689,454 | $658,763 | $276,280 | $781,897 | $116,414 | $810 | $3,725,341 |
| Total year-to-date gross charge-offs | $573 | $17,376 | $25,910 | $12,661 | $5,262 | $1,307 | $— | $— | $63,089 |
The following tables present the Company’s loan portfolio delinquency, including nonperforming loans, as of September 30, 2026 and December 31, 2025.
| (amounts in thousands) | 30-59DaysPast Due | 60-89DaysPast Due | 90 Days or MorePast Due | Total Past Due | Current | TotalLoans |
|---|---|---|---|---|---|---|
| Commercial and industrial | $718 | $852 | $1,103 | $2,673 | $234,994 | $237,667 |
| Owner-occupied commercial real estate | — | — | — | — | 50,082 | 50,082 |
| Investor commercial real estate | — | — | — | — | 753,690 | 753,690 |
| Construction | — | — | — | — | 400,302 | 400,302 |
| Single tenant lease financing | — | — | — | — | 308,594 | 308,594 |
| Public finance | — | — | — | — | 430,381 | 430,381 |
| Healthcare finance | 564 | — | 130 | 694 | 111,712 | 112,406 |
| Small business lending | 5,198 | 639 | 14,473 | 20,310 | 419,025 | 439,335 |
| Franchise finance | 3,538 | 3,903 | 20,604 | 28,045 | 302,581 | 330,626 |
| Residential mortgage | 2,651 | 1,862 | 2,199 | 6,712 | 313,260 | 319,972 |
| Home equity | — | — | — | — | 16,186 | 16,186 |
| Other consumer loans | 304 | 153 | 57 | 514 | 445,793 | 446,307 |
| Total | $12,973 | $7,409 | $38,566 | $58,948 | $3,786,600 | $3,845,548 |
| (amounts in thousands) | 30-59DaysPast Due | 60-89DaysPast Due | 90 Days or MorePast Due | Total Past Due | Current | TotalLoans |
|---|---|---|---|---|---|---|
| Commercial and industrial | $515 | $200 | $— | $715 | $220,999 | $221,714 |
| Owner-occupied commercial real estate | — | — | — | — | 48,575 | 48,575 |
| Investor commercial real estate | — | — | — | — | 647,394 | 647,394 |
| Construction | — | — | — | — | 372,668 | 372,668 |
| Single tenant lease financing | — | — | — | — | 222,925 | 222,925 |
| Public finance | — | — | — | — | 442,234 | 442,234 |
| Healthcare finance | — | — | 1,150 | 1,150 | 138,319 | 139,469 |
| Small business lending | 20,325 | 4,277 | 9,445 | 34,047 | 395,977 | 430,024 |
| Franchise finance | 11,641 | 1,110 | 24,912 | 37,663 | 379,382 | 417,045 |
| Residential mortgage | — | 3,079 | 4,622 | 7,701 | 335,409 | 343,110 |
| Home equity | — | — | — | — | 14,725 | 14,725 |
| Other consumer loans | 243 | 102 | 141 | 486 | 424,972 | 425,458 |
| Total | $32,724 | $8,768 | $40,270 | $81,762 | $3,643,579 | $3,725,341 |
Loans are reclassified to a non-accruing status when, in management’s judgment, the collateral value and financial condition of the borrower do not justify accruing interest. At the time the accrual is discontinued, all unpaid accrued interest is reversed against earnings. Interest income accrued in prior years, if any, is charged to the allowance for credit losses. Payments subsequently received on nonaccrual loans are applied to principal. A loan is returned to accrual status when principal and interest are no longer past due and collectability is probable, typically after a minimum of nine consecutive months of performance.
The following table summarizes the Company’s nonaccrual loans and loans past due 90 days or more and still accruing by loan class for the periods indicated:
| September 30, 2026 | December 31, 2025 | |||||
|---|---|---|---|---|---|---|
| (amounts in thousands) | Nonaccrual Loans | Nonaccrual Loans with No Allowance for Credit Losses | Total Loans90 Days orMore PastDue andAccruing | Nonaccrual Loans | Nonaccrual Loans with No Allowance for Credit Losses | Total Loans90 Days orMore PastDue andAccruing |
| Commercial and industrial | $606 | $305 | $682 | $240 | $— | $— |
| Single tenant lease financing | — | — | — | 1,665 | — | — |
| Healthcare finance | 130 | 130 | — | 2,596 | 2,596 | — |
| Small business lending 1 | 24,872 | 23,511 | 21 | 19,781 | 18,928 | — |
| Franchise finance | 30,837 | 800 | — | 26,978 | 4,463 | 1,144 |
| Residential mortgage | 5,780 | 5,780 | — | 4,893 | 4,893 | 1,007 |
| Other consumer loans | 128 | 128 | — | 234 | 234 | — |
| Total loans | $62,353 | $30,654 | $703 | $56,387 | $31,114 | $2,151 |
1 Balance includes $19.2 million and $13.6 million at September 30, 2026 and December 31, 2025, respectively, of loans guaranteed by the U.S. government.
Interest income recognized on nonaccrual loans was $0.3 million and $0.7 million for the three and nine months ended September 30, 2026, respectively, and $0.1 million and $1.1 million for the three and nine months ended September 30, 2025, respectively.
Determining fair value for collateral dependent loans requires obtaining a current independent appraisal of the collateral and applying a discount factor, which includes selling costs if applicable, to the value. The fair value of real estate is generally based on appraisals by qualified licensed appraisers. The appraisers typically determine the value of the real estate by utilizing an income or market valuation approach. If an appraisal is not available, the fair value may be determined by using a cash flow analysis. Fair value on other collateral such as business assets is typically ascertained by assessing, either singularly or some combination of, asset appraisals, accounts receivable aging reports, inventory listings and/or customer financial statements.
The following tables present the amortized cost basis of collateral dependent loans, which are individually evaluated to determine expected credit losses as of September 30, 2026 and December 31, 2025.
| (amounts in thousands) | Commercial Real Estate | Residential Real Estate | Other (Includes Equipment, Machinery and Other Assets) | Total | Allowance on Collateral Dependent Loans |
|---|---|---|---|---|---|
| Commercial and industrial | $100 | $— | $— | $100 | $36 |
| Healthcare finance | — | 130 | — | 130 | — |
| Small business lending 1 | 9,678 | — | 3,302 | 12,980 | 359 |
| Residential mortgage | — | 5,780 | — | 5,780 | — |
| Other consumer loans | — | — | 128 | 128 | — |
| Total loans | $9,778 | $5,910 | $3,430 | $19,118 | $395 |
1 Balance includes $7.9 million of loans guaranteed by the U.S. government.
| (amounts in thousands) | Commercial Real Estate | Residential Real Estate | Other (Includes Equipment, Machinery and Other Assets) | Total | Allowance on Collateral Dependent Loans |
|---|---|---|---|---|---|
| Owner-occupied commercial real estate | $1,654 | $— | $— | $1,654 | $— |
| Small business lending 1 | 6,732 | — | 7,681 | 14,413 | 411 |
| Residential mortgage | — | 4,893 | — | 4,893 | — |
| Other consumer loans | — | — | 234 | 234 | — |
| Total loans | $8,386 | $4,893 | $7,915 | $21,194 | $411 |
1 Balance includes $8.5 million of loans guaranteed by the U.S. government.
Loan Modifications to Borrowers Experiencing Financial Difficulty
The Company may agree to modify the contractual terms of a loan to a borrower experiencing financial difficulty as a part of ongoing loss mitigation strategies. These modifications may include interest rate reductions, principal or interest forgiveness, other-than-insignificant payment delays, term extensions and other actions intended to minimize loss and to avoid foreclosure or repossession of collateral.
The Company hadsixteen loan modifications made to borrowers experiencing financial difficulty during the three months ended September 30, 2026. The Company hadthirty-one loan modifications made to borrowers experiencing financial difficulty during the nine months ended September 30, 2026. The Company hadone loan modification made to borrowers experiencing financial difficulty during the three months ended September 30, 2025. The Company hadten loan modifications made to borrowers experiencing financial difficulty during the nine months ended September 30, 2025.
The following tables present loans that were both experiencing financial difficulty and modified during the three months ended September 30, 2026 and 2025.
| (dollars in thousands) | Other-Than-Insignificant Payment Delay | Term Extension | Combination - Other-Than-Insignificant Payment Delay & Term Extension | Total Modification by Loan Class | % of Class of Loans |
|---|---|---|---|---|---|
| Commercial and industrial | $243 | $— | $— | $243 | 0.1% |
| Small business lending | 1,096 | 868 | 1,795 | 3,759 | 0.9% |
| Franchise finance | 8,246 | — | — | 8,246 | 2.5% |
| Total | $9,585 | $868 | $1,795 | $12,248 |
| (dollars in thousands) | Other-Than-Insignificant Payment Delay | Total Modification by Loan Class | % of Class of Loans |
|---|---|---|---|
| Franchise finance | $562 | $562 | 0.1% |
| Total | $562 | $562 |
The following table presents loans that were both experiencing financial difficulty and modified during the nine months ended September 30, 2026 and 2025.
| (dollars in thousands) | Other-Than-Insignificant Payment Delay | Term Extension | Combination - Other-Than-Insignificant Payment Delay & Term Extension | Total Modification by Loan Class | % of Class of Loans |
|---|---|---|---|---|---|
| Commercial and industrial | $245 | $— | $— | $245 | 0.1% |
| Small business lending | 1,096 | 1,946 | 5,632 | 8,674 | 2.0% |
| Franchise finance | 8,860 | — | — | 8,860 | 2.7% |
| Residential mortgage | — | 95 | — | 95 | —% |
| Total | $10,201 | $2,041 | $5,632 | $17,874 |
| (dollars in thousands) · Other-Than-Insignificant Payment Delay · Total Modification by Loan Class · % of Class of Loans | |||||
|---|---|---|---|---|---|
| Commercial and industrial | $386 | $386 | 0.2% | ||
| Single tenant lease financing | 4,672 | 4,672 | 4.3% | ||
| Healthcare finance | 2,610 | 2,610 | 1.7% | ||
| Small business lending | 3,013 | 3,013 | 0.8% | ||
| Franchise finance | 562 | 562 | 0.1% | ||
| Total | $11,243 | $11,243 | |||
The following tables summarize the financial impacts of loan modifications made to borrowers experiencing financial difficulty during the periods presented. There were no financial impacts of loan modifications made to borrowers experiencing financial difficulty during the three and nine months ended September 30, 2025.
| Weighted Average Term Extension (in Months) | |
|---|---|
| Small business lending | 108 |
| Weighted Average Term Extension (in Months) | |
|---|---|
| Small business lending | 109 |
| Residential mortgage | 7 |
The Company closely monitors the performance of loans that are modified to borrowers experiencing financial difficulty to understand the effectiveness of its modification efforts. The following table presents the performance of loans that were modified within the twelve months ended September 30, 2026.
| (amounts in thousands) | Current | 30 - 89 Days Past Due | 90+ Days Past Due |
|---|---|---|---|
| Commercial and industrial | $127 | $— | $118 |
| Healthcare finance | — | — | 130 |
| Small business lending | 8,304 | 370 | 20 |
| Franchise finance | 8,860 | — | — |
| Residential mortgage | 95 | — | — |
| Total | $17,386 | $370 | $268 |
The following table presents the loans that were modified during the preceding twelve months and subsequently defaulted during the period.
| (dollars in thousands) | Other-Than-Insignificant Payment Delay | Term Extension | Combination - Other-Than-Insignificant Payment Delay & Term Extension | Total |
|---|---|---|---|---|
| Commercial and industrial | $118 | $— | $— | $118 |
| Small business lending | — | — | 125 | 125 |
| Total | $118 | $— | $125 | $243 |
| (dollars in thousands) | Other-Than-Insignificant Payment Delay | Term Extension | Combination - Other-Than-Insignificant Payment Delay & Term Extension | Total |
|---|---|---|---|---|
| Commercial and industrial | $118 | $— | $— | $118 |
| Healthcare finance | 130 | — | — | 130 |
| Small business lending | 73 | — | 125 | 198 |
| Total | $321 | $— | $125 | $446 |
At September 30, 2025, there wereno loans that defaulted after being modified during the preceding twelve months.
Other Real Estate Owned
The Company had $4.1 million in other real estate owned (“OREO”) as of September 30, 2026, which consisted ofone residential property, three small business lending properties, andone single tenant lease financing property. The Company had $2.6 million in OREO as of December 31, 2025, which consisted ofthree small business lending properties. There were seven loans totaling $1.6 million andeight loans totaling $2.5 million, in the process of foreclosure at September 30, 2026 and December 31, 2025, respectively.
Note 5: Premises and Equipment
The following table summarizes premises and equipment at September 30, 2026 and December 31, 2025.
| (amounts in thousands) | September 30, 2026 | December 31, 2025 |
|---|---|---|
| Land | $5,598 | $5,598 |
| Construction in process | — | 17 |
| Right of use leased asset | 9 | 88 |
| Building and improvements | 63,316 | 63,382 |
| Furniture and equipment | 23,144 | 22,818 |
| Less: accumulated depreciation | (27,529) | (23,969) |
| Total | $64,538 | $67,934 |
Note 6: Goodwill
As of September 30, 2026 and December 31, 2025, the carrying amount of goodwill was $4.7 million. There have beenno changes in the carrying amount of goodwill for the three and nine months ended September 30, 2026 or September 30, 2025. Goodwill is assessed for impairment annually as of August 31, or more frequently if events occur or circumstances change that indicate an impairment may exist. When assessing goodwill for impairment, first, a qualitative assessment can be made to determine whether it is more likely than not that the estimated fair value of a reporting unit is less than its estimated carrying value. If the results of the qualitative assessment are not conclusive, a quantitative goodwill test is performed. Alternatively, a quantitative goodwill test can be performed without performing a qualitative assessment.
Goodwill was assessed for impairment using a quantitative test performed as of August 31, 2026. The estimated fair value of the reporting unit exceeded the net carrying value, and thereforeno goodwill impairment existed as of that date. However, there is a risk for impairment in the event of declines in general economic, market or business conditions and the resultant effect on forecasted growth rates, or any significant unfavorable change in the Company’s forecasted operations resulting from elevated levels of net charge-offs in the franchise finance and small business lending portfolios. If current and long-term projections decrease materially, the Company may be required to recognize impairment charges, which could be material to the results of operations.
Note 7: Servicing Asset
Activity for the servicing asset and the related changes in fair value for the three and nine months ended September 30, 2026 and 2025 are shown in the tables below.
| Three Months Ended | ||
|---|---|---|
| (amounts in thousands) | September 30, 2026 | September 30, 2025 |
| Balance, beginning of period | $23,180 | $16,736 |
| Additions: | ||
| Originated 1 | 1,401 | 6,703 |
| Subtractions: | ||
| Paydowns | (1,548) | (903) |
| Changes in fair value due to changes in valuation inputs or assumptions used in the valuation model | 587 | (429) |
| Loan servicing asset revaluation | $(961) | $(1,332) |
| Balance, end of period | $23,620 | $22,107 |
1 Balance includes $3.8 million of originated servicing asset related to the sale of single tenant lease financing loans that was completed during the three months ended September 30, 2025.
| Nine Months Ended | ||
|---|---|---|
| (amounts in thousands) | September 30, 2026 | September 30, 2025 |
| Balance, beginning of period | $22,793 | $16,389 |
| Additions: | ||
| Originated 1 | 4,427 | 9,384 |
| Subtractions: | ||
| Paydowns | (4,789) | (2,714) |
| Changes in fair value due to changes in valuation inputs or assumptions used in the valuation model | 1,189 | (952) |
| Loan servicing asset revaluation | $(3,600) | $(3,666) |
| Balance, end of period | $23,620 | $22,107 |
1 Balance includes $3.8 million of originated servicing asset related to the sale of single tenant lease financing loans that was completed during the nine months ended September 30, 2025.
Loans serviced for others are not included in the condensed consolidated balance sheets. The unpaid principal balances of these loans serviced for others as of September 30, 2026 and December 31, 2025 are shown in the table below.
| (amounts in thousands) | September 30, 2026 | December 31, 2025 |
|---|---|---|
| Loan portfolios serviced for: | ||
| SBA guaranteed loans | $1,216,623 | $1,120,553 |
| Single tenant lease financing | 691,561 | 825,207 |
| Total | $1,908,184 | $1,945,760 |
Loan servicing revenue totaled $2.8 million and $8.5 million for the three and nine months ended September 30, 2026 respectively, and $2.1 million and $6.0 million for the three and nine months ended September 30, 2025, respectively. Loan servicing asset revaluation, which represents the change in fair value of the servicing asset, resulted in a $1.0 million and $3.6 million downward valuation for the three and nine months ended September 30, 2026, respectively, and $1.3 million and $3.7 million downward valuation for the three and nine months ended September 30, 2025, respectively.
The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Though fluctuations in prepayment speeds and changes in secondary market premiums generally have the most substantial impact on the fair value of servicing rights, other influencing factors include changing economic conditions, changes to the discount rate assumption and the weighted average life of the servicing portfolio. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time; however, those assumptions may change over time. Refer to Note 11 - Fair Value of Financial Instruments for further details.
Note 8: Subordinated Debt
In June 2019, the Company issued $37.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2029 (the “2029 Notes”) in a public offering. The 2029 Notes bear interest at a floating rate equal to three-month Term SOFR plus 4.376%. All interest on the 2029 Notes is payable quarterly. The 2029 Notes are scheduled to mature on June 30, 2029. The 2029 Notes are unsecured subordinated obligations of the Company and may be repaid at any time, without penalty. The 2029 Notes are intended to qualify as Tier 2 capital under regulatory guidelines.
In October 2020, the Company entered into a term loan in the principal amount of $10.0 million, evidenced by a term note due 2030 (the “2030 Note”). The 2030 Note initially accrued interest at a fixed rate of 6.0% per year to, but excluding, November 1, 2025 and thereafter at a floating rate equal to three-month Term SOFR plus 5.795%. The 2030 Note is an unsecured subordinated obligation of the Company and may be repaid, without penalty, on any interest payment date. The 2030 Note is intended to qualify as Tier 2 capital under regulatory guidelines. The Company used the net proceeds from the issuance of the 2030 Note to redeem a subordinated term note that had been entered into in October 2015. Subsequent to September 30, 2026, the Company redeemed the 2030 Note in full, without penalty, with a redemption date of November 1, 2026 and payment of the redemption price made on November 2, 2026, using a portion of the net proceeds from the issuance of the 2036 Notes mentioned below.
In August 2021, the Company issued $60.0 million aggregate principal amount of 3.75% Fixed-to-Floating Rate Subordinated Notes due 2031 (the “2031 Notes”) in a private placement. The 2031 Notes bear interest at a floating rate equal to three-month Term SOFR plus 3.11%. The 2031 Notes are scheduled to mature on September 1, 2031. The 2031 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date. The 2031 Notes are intended to qualify as Tier 2 capital under regulatory guidelines. The Company used a portion of the net proceeds from the issuance of the 2031 Notes to redeem subordinated notes issued by the Company in 2016. Pursuant to the terms of a Registration Rights Agreement between the Company and the initial purchasers of the 2031 Notes, the Company offered to exchange the 2031 Notes for subordinated notes that are registered under the Securities Act of 1933, as amended, and have substantially the same terms as the 2031 Notes. On December 30, 2021, we completed an exchange of $59.3 million principal amount of the unregistered 2031 Notes for registered 2031 Notes in satisfaction of our obligations under the registration rights agreement. Holders of $0.7 million of unregistered 2031 Notes did not participate in the exchange.
In September 2026, the Company issued $20.5 million aggregate principal amount of 8.00% Fixed-to-Floating Rate Subordinated Notes due 2036 (the “2036 Notes”) in a private placement. The 2036 Notes initially bear a fixed interest rate of 8.00% per year to, but excluding, September 15, 2031, and thereafter at a floating rate equal to the then-current benchmark rate (initially three-month Term SOFR) plus 3.735%. The 2036 Notes are scheduled to mature on September 15, 2036. The 2036 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after September 15, 2031. The 2036 Notes are intended to qualify as Tier 2 capital under regulatory guidelines. The Company used the net proceeds from the issuance of the 2036 Notes to retire $2.0 million in aggregate principal amount of the 2029 Notes and used $10.0 million of the net proceeds to redeem the 2030 Note in full, with a redemption date of November 1, 2026 and payment made on November 2, 2026. Under the terms of a Registration Rights Agreement between the Company and the initial purchasers of the 2036 Notes, the Company has agreed to take certain actions to provide for the exchange of the 2036 Notes for subordinated notes that are registered under the Securities Act of 1933, as amended, and have substantially the same terms as the 2036 Notes.
The following table presents the principal balance and unamortized discount and debt issuance costs for the 2029 Notes, the 2030 Note, the 2031 Notes, and the 2036 Notes as of September 30, 2026 and December 31, 2025.
| September 30, 2026 | December 31, 2025 | |||
|---|---|---|---|---|
| (amounts in thousands) | Principal | Unamortized Discount and Debt Issuance Costs | Principal | Unamortized Discount and Debt Issuance Costs |
| 2029 Notes | $35,000 | $(404) | $37,000 | $(546) |
| 2030 Note | 10,000 | (96) | 10,000 | (114) |
| 2031 Notes | 60,000 | (771) | 60,000 | (875) |
| 2036 Notes | 20,500 | (723) | — | — |
| Total | $125,500 | $(1,994) | $107,000 | $(1,535) |
Note 9: Benefit Plans
Employment Agreements
The Company is party to certain employment agreements with each of its Chief Executive Officer, President and Chief Operating Officer, and Executive Vice President and Chief Financial Officer. The employment agreements each provide for annual base salaries and annual bonuses, if any, as determined from time to time by the Compensation Committee of our Board of Directors. The annual bonuses are to be determined with reference to the achievement of annual performance objectives established by the Compensation Committee. The agreements also provide that each of the Chief Executive Officer, President and Chief Operating Officer, and Executive Vice President and Chief Financial Officer, may be awarded additional compensation, benefits, or consideration as the Compensation Committee may determine.
The agreements also provide for the continuation of salary and certain other benefits for a specified period of time upon termination of employment under certain circumstances, including resignation for “good reason,” termination by the Company without “cause” at any time or any termination of employment within twelve months following a “change in control,” along with other specific conditions.
2022 Equity Incentive Plan
The First Internet Bancorp 2022 Equity Incentive Plan (the “2022 Plan”) was approved by our Board of Directors and ratified by our shareholders on May 16, 2022. The plan permits awards of incentive and non-statutory stock options, stock appreciation rights, restricted stock awards, stock unit awards, performance awards and other stock-based awards. All employees, consultants and advisors of the Company or any subsidiary, as well as all non-employee directors of the Company, are eligible to receive awards under the 2022 Plan. The 2022 Plan initially authorized the issuance of 400,000 new shares of the Company’s common stock plus all shares of common stock that remained available for future grants under the First Internet Bancorp 2013 Equity Incentive Plan (the “2013 Plan”).
Award Activity Under 2022 Plan
The Company recorded $0.5 million and $1.7 million of share-based compensation expense for the three and nine months ended September 30, 2026, respectively, and $0.5 million and $0.9 million of share-based compensation expense for the three and nine months ended September 30, 2025, respectively, related to stock-based awards under the 2022 Plan.
The following table summarizes the stock-based award activity under the 2022 Plan for the nine months ended September 30, 2026.
| (dollars in thousands, except per share data) | Restricted Stock Units | Weighted-Average Grant Date Fair Value Per Share | Restricted Stock Awards | Weighted-Average Grant Date Fair Value Per Share | Deferred Stock Units | Weighted-Average Grant Date Fair Value Per Share |
|---|---|---|---|---|---|---|
| Unvested at December 31, 2025 | 157,504 | $27.97 | 16,009 | $24.72 | — | $— |
| Granted | 111,953 | 21.30 | 16,912 | 23.82 | — | — |
| Cancelled/Forfeited | (9,462) | 24.84 | — | — | — | — |
| Vested | (39,417) | 27.28 | (16,009) | 24.72 | — | — |
| Unvested at September 30, 2026 | 220,578 | $25.08 | 16,912 | $23.82 | — | $— |
At September 30, 2026, the total unrecognized compensation cost related to unvested stock-based awards under the 2022 Plan was$2.7 million with a weighted-average expense recognition period of 1.7 years.
2013 Equity Incentive Plan
The 2013 Plan authorized the issuance of 750,000 shares of the Company’s common stock in the form of stock-based awards to employees, directors, and other eligible persons. No awards under the 2013 Plan remain outstanding and our authority to grant new awards under the 2013 Plan terminated upon shareholder approval of the 2022 Plan.
Award Activity Under 2013 Plan
The Company recordedno share-based compensation expense for the three and nine months ended September 30, 2026, related to stock-based awards under the 2013 Plan. The Company recordedno share-based compensation expense for the three months ended September 30, 2025, and less than $0.1 millionof share-based compensation expense for the nine
months ended September 30, 2025, related to stock-based awards under the 2013 Plan.
At September 30, 2026, there wereno unrecognized compensation costs related to unvested stock-based awards under the 2013 Plan.
Directors Deferred Stock Plan
Until January 2014, the Company had a practice of granting awards under a stock compensation plan for members of the Board of Directors (“Directors Deferred Stock Plan”). The Company reserved 180,000 shares of common stock that could have been issued pursuant to the Directors Deferred Stock Plan. The plan provided directors the option to elect to receive up to 100% of their annual retainer in either common stock or deferred stock rights. Deferred stock rights were to be settled in common stock following the end of the deferral period payable on the basis ofone share of common stock for each deferred stock right.
The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the nine months ended September 30, 2026.
| Deferred Stock Rights | |
|---|---|
| Outstanding, beginning of period | 29,013 |
| Granted | 253 |
| Outstanding, end of period | 29,266 |
All deferred stock rights granted during the 2026 period were additional rights issued in lieu of cash dividends payable on outstanding deferred stock rights.
Note 10: Commitments and Credit Risk
In the normal course of business, the Company makes various commitments to extend credit which are not reflected in the accompanying condensed consolidated financial statements. At September 30, 2026 and December 31, 2025, the Company had outstanding loan commitments totaling approximately $536.6 million and $617.6 million, respectively.
Note 11: Fair Value of Financial Instruments
ASC Topic 820, Fair Value Measurement, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also specifies a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:
Level 1 Quoted prices in active markets for identical assets or liabilities
Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities
Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities
Following is a description of the valuation methodologies and inputs used for assets measured at fair value on a recurring basis and recognized in the accompanying condensed consolidated balance sheets, as well as the general classification of such assets pursuant to the valuation hierarchy.
Available-for-Sale Securities
Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows. The Company did not own any securities classified within Level 1 of the hierarchy as of September 30, 2026 and December 31, 2025.
Level 2 securities include U.S. Government-sponsored agencies, municipal securities, mortgage and asset-backed securities and corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities.
In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of September 30, 2026 or December 31, 2025.
Servicing Asset
Fair value is based on a loan-by-loan basis taking into consideration the origination to maturity dates of the loans, the current age of the loans and the remaining term to maturity. The valuation methodology utilized for the servicing asset begins with generating estimated future cash flows for each servicing asset based on their unique characteristics and market-based assumptions for prepayment speeds and costs to service. The present value of the future cash flows is then calculated utilizing market-based discount rate assumptions (Level 3).
Interest Rate Swap Agreements Back-to-Back
The Company offers interest rate swaps to certain loan customers to allow them to hedge the risk of rising interest rates on their variable rate loans. The Company originates a variable rate loan and enters into a variable-to-fixed interest rate contract with the customer. The Company also enters into an offsetting interest rate swap with a correspondent bank. These back-to-back swap agreements are intended to offset each other and allow the Company to originate a variable rate loan, while providing a contract for fixed interest payments for the customer. The net cash flow for the Company is equal to the interest income received from a variable rate loan originated with the customer. The fair value of these derivatives is based on a discounted cash flow approach. The fair value assets and liabilities of centrally clear interest rate swaps are net of variation margin settled-to-market (Level 2).
The following tables present the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at September 30, 2026 and December 31, 2025.
| September 30, 2026 Fair Value Measurements Using | ||||
|---|---|---|---|---|
| (amounts in thousands) | FairValue | Quoted Pricesin Active Markets for Identical Assets(Level 1) | SignificantOtherObservableInputs(Level 2) | SignificantUnobservableInputs(Level 3) |
| U.S. Government-sponsored agencies | $49,805 | $— | $49,805 | $— |
| Municipal securities | 50,585 | — | 50,585 | — |
| Agency mortgage-backed securities - residential | 410,981 | — | 410,981 | — |
| Agency mortgage-backed securities - commercial | 55,092 | — | 55,092 | — |
| Private label mortgage-backed securities - residential | 118,857 | — | 118,857 | — |
| Asset-backed securities | 81,260 | — | 81,260 | — |
| Corporate securities | 76,528 | — | 76,528 | — |
| Total available-for-sale securities | $843,108 | $— | $843,108 | $— |
| Servicing asset | 23,620 | — | — | 23,620 |
| Interest rate swap agreements - assets (back-to-back) | 460 | — | 460 | — |
| Interest rate swap agreements - liabilities (back-to-back) | (460) | — | (460) | — |
| December 31, 2025Fair Value Measurements Using | ||||
|---|---|---|---|---|
| (amounts in thousands) | FairValue | Quoted Pricesin Active Markets for Identical Assets(Level 1) | SignificantOtherObservableInputs(Level 2) | SignificantUnobservableInputs(Level 3) |
| U.S. Government-sponsored agencies | $63,764 | $— | $63,764 | $— |
| Municipal securities | 63,386 | — | 63,386 | — |
| Agency mortgage-backed securities - residential | 389,457 | — | 389,457 | — |
| Agency mortgage-backed securities - commercial | 58,477 | — | 58,477 | — |
| Private label mortgage-backed securities - residential | 123,673 | — | 123,673 | — |
| Asset-backed securities | 42,553 | — | 42,553 | — |
| Corporate securities | 37,377 | — | 37,377 | — |
| Total available-for-sale securities | $778,687 | $— | $778,687 | $— |
| Servicing asset | 22,793 | — | — | 22,793 |
| Interest rate swap agreements - assets (back-to-back) | 210 | — | 210 | — |
| Interest rate swap agreements - liabilities (back-to-back) | (210) | — | (210) | — |
The following tables reconcile the beginning and ending balances of recurring fair value measurements recognized in the accompanying condensed consolidated balance sheets using significant unobservable (Level 3) inputs for the three and nine months ended September 30, 2026 and 2025.
| Three Months Ended | |
|---|---|
| (amounts in thousands) | Servicing Asset |
| Balance as of July 1, 2026 | $23,180 |
| Total realized gains | |
| Additions | 1,401 |
| Paydowns | (1,548) |
| Change in fair value | 587 |
| Balance as of September 30, 2026 | $23,620 |
| Balance as of July 1, 2025 | $16,736 |
| Total realized gains | |
| Additions | 6,703 |
| Paydowns | (903) |
| Change in fair value | (429) |
| Balance as of September 30, 2025 | $22,107 |
| Nine Months Ended | |
|---|---|
| (amounts in thousands) | Servicing Asset |
| Balance as of January 1, 2026 | $22,793 |
| Total realized gains | |
| Additions | 4,427 |
| Paydowns | (4,789) |
| Change in fair value | 1,189 |
| Balance as of September 30, 2026 | $23,620 |
| Balance as of January 1, 2025 | $16,389 |
| Total realized gains | |
| Additions | 9,384 |
| Paydowns | (2,714) |
| Change in fair value | (952) |
| Balance as of September 30, 2025 | $22,107 |
The following describes the valuation methodologies and inputs used for assets measured at fair value on a nonrecurring basis, as well as the general classification of such assets pursuant to the valuation hierarchy.
Individually Analyzed Collateral Dependent Loans
Loans for which it is probable that the Company will not collect all principal and interest due according to contractual terms are measured for impairment. The amount of impairment may be determined based on the fair value of the underlying collateral, less costs to sell, the estimated present value of future cash flows, or the loan’s observable market price.
If the individually evaluated loan is identified as collateral dependent, the fair value of the underlying collateral, less costs to sell, is used to measure impairment. This method requires obtaining a current independent appraisal of the collateral and applying a discount factor to the value. For individually evaluated loans that are not collateral-dependent, the Company measures impairment by using a discounted cash flow analysis, an enterprise value approach based on the borrower's sustainable earnings and estimated net realizable business value, or a guarantor-based estimated recovery approach that incorporates the guarantor's financial capacity, creditworthiness, and expected collection outcome. The method selected is based on the specific facts and circumstances of the loan relationship.
Individually evaluated loans with a specific valuation allowance based on the value of the underlying collateral, a discounted cash flow analysis or other valuation method are classified as Level 3 assets.
The following table presents the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurement falls at September 30, 2026 and December 31, 2025.
| Fair Value Measurements Using | ||||
|---|---|---|---|---|
| (amounts in thousands) | FairValue | Quoted Pricesin ActiveMarkets forIdenticalAssets(Level 1) | SignificantOtherObservableInputs(Level 2) | SignificantUnobservableInputs(Level 3) |
| Collateral dependent loans | $438 | $— | $— | $438 |
| Other real estate owned | 4,141 | — | — | 4,141 |
| Fair Value Measurements Using | ||||
|---|---|---|---|---|
| (amounts in thousands) | FairValue | Quoted Pricesin ActiveMarkets forIdenticalAssets(Level 1) | SignificantOtherObservableInputs(Level 2) | SignificantUnobservableInputs(Level 3) |
| Collateral dependent loans | $336 | $— | $— | $336 |
| Other real estate owned | 2,631 | — | — | 2,631 |
Significant Unobservable (Level 3) Inputs
The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements.
| (dollars in thousands) | Fair Value atSeptember 30, 2026 | ValuationTechnique | Significant UnobservableInputs | Range | Weighted-Average Range |
|---|---|---|---|---|---|
| Collateral dependent loans | $438 | Fair value of collateral | Discount for type of property and current market conditions | 0% - 50% | 29.1% |
| Servicing asset | 23,620 | Discounted cash flow | Prepayment speedsDiscount rate | 10% - 13%13% - 14% | 12.5%13.2% |
| Other real estate owned | 4,141 | Fair value of collateral | Discount to reflect current market conditions | 0% - 31% | 19.5% |
| (dollars in thousands) | Fair Value atDecember 31, 2025 | ValuationTechnique | Significant UnobservableInputs | Range | Weighted-Average Range |
|---|---|---|---|---|---|
| Collateral dependent loans | $336 | Fair value of collateral | Discount for type of property and current market conditions | 0% - 40% | 30.8% |
| Servicing asset | 22,793 | Discounted cash flow | Prepayment speedsDiscount rate | 0% - 25%13% - 15% | 11.9%13.0% |
| Other real estate owned | 2,631 | Fair value of collateral | Discount to reflect current market conditions | 30% - 35% | 32.0% |
The following methods were used to estimate the fair value of all other financial instruments recognized in the accompanying condensed consolidated balance sheets at amounts other than fair value.
Cash and Cash Equivalents
For these instruments, the carrying amount is a reasonable estimate of fair value.
Securities Held-to-Maturity
Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows.
Level 2 securities include agency mortgage-backed securities - residential, municipal securities and corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities.
In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of September 30, 2026 or December 31, 2025.
Loans Held-for-Sale
For loans that are sold in an active secondary market, the fair value of these loans is estimated based on secondary market price indications for loans with similar interest rate and maturity characteristics. The fair value of other loans held-for-sale approximates carrying value.
Net Loans
The fair value of loans is estimated on an exit price basis incorporating discounts for credit, liquidity and marketability factors.
Accrued Interest Receivable
The fair value of these financial instruments approximates carrying value.
Federal Home Loan Bank of Indianapolis Stock
The fair value of this financial instrument approximates carrying value.
Deposits
The fair value of noninterest-bearing and interest-bearing demand deposits, savings and money market accounts approximates carrying value. The fair value of fixed maturity certificates of deposit and brokered deposits are estimated using rates currently offered for deposits of similar remaining maturities.
Advances from Federal Home Loan Bank
The fair value of fixed rate advances is estimated using rates currently available for advances with similar remaining maturities. The carrying value of variable rate advances approximates fair value.
Subordinated Debt
The fair value of the Company’s publicly traded subordinated debt is obtained from quoted market prices. The fair value of the Company’s remaining subordinated debt is estimated using discounted cash flow analysis, based on current borrowing rates for similar types of debt instruments.
Accrued Interest Payable
The fair value of these financial instruments approximates carrying value.
Commitments
The fair value of commitments to extend credit are based on fees currently charged to enter into similar agreements with similar maturities and interest rates. The Company determined that the fair value of commitments was zero based on the contractual value of outstanding commitments at each of September 30, 2026 and December 31, 2025.
The following tables present the carrying value and estimated fair value of all financial assets and liabilities that are not measured at fair value on a recurring basis at September 30, 2026 and December 31, 2025.
| September 30, 2026Fair Value Measurements Using | |||||
|---|---|---|---|---|---|
| (amounts in thousands) | CarryingAmount | Fair Value | Quoted PricesIn ActiveMarkets forIdentical Assets(Level 1) | SignificantOtherObservableInputs(Level 2) | SignificantUnobservableInputs(Level 3) |
| Cash and cash equivalents | $652,274 | $652,274 | $652,274 | $— | $— |
| Securities held-to-maturity, net | 255,934 | 228,694 | — | 228,694 | — |
| Loans held-for-sale | 34,855 | 38,072 | — | 38,072 | — |
| Net loans | 3,806,623 | 3,712,400 | — | — | 3,712,400 |
| Accrued interest receivable | 28,565 | 28,565 | 28,565 | — | — |
| Federal Home Loan Bank of Indianapolis stock | 28,350 | 28,350 | — | 28,350 | — |
| Deposits | 5,152,766 | 5,000,118 | 3,122,934 | — | 1,877,184 |
| Advances from Federal Home Loan Bank | 239,500 | 235,769 | — | 235,769 | — |
| Subordinated debt | 123,506 | 125,545 | 35,140 | 90,405 | — |
| Accrued interest payable | 1,298 | 1,298 | 1,298 | — | — |
| December 31, 2025Fair Value Measurements Using | |||||
|---|---|---|---|---|---|
| (amounts in thousands) | CarryingAmount | Fair Value | Quoted PricesIn ActiveMarkets forIdenticalAssets(Level 1) | SignificantOtherObservableInputs(Level 2) | SignificantUnobservableInputs(Level 3) |
| Cash and cash equivalents | $456,777 | $456,777 | $456,777 | $— | $— |
| Securities held-to-maturity, net | 250,609 | 238,815 | — | 238,815 | — |
| Loans held-for-sale | 108,608 | 117,917 | — | 117,917 | — |
| Net loans | 3,691,042 | 3,642,632 | — | — | 3,642,632 |
| Accrued interest receivable | 27,909 | 27,909 | 27,909 | — | — |
| Federal Home Loan Bank of Indianapolis stock | 28,350 | 28,350 | — | 28,350 | — |
| Deposits | 4,839,813 | 4,853,941 | 2,559,565 | — | 2,294,376 |
| Advances from Federal Home Loan Bank | 249,500 | 252,046 | — | 252,046 | — |
| Subordinated debt | 105,465 | 105,492 | 37,059 | 68,433 | — |
| Accrued interest payable | 1,744 | 1,744 | 1,744 | — | — |
Note 12: Derivative Financial Instruments
The Company uses derivative financial instruments from time to time to help manage exposure to interest rate risk and the effects that changes in interest rates may have on net income and the fair value of assets and liabilities. The Company enters into interest rate swap agreements as part of its asset/liability management strategy to help manage its interest rate risk position.
The Company entered into offsetting interest rate swaps with a correspondent bank. These back-to-back swap agreements are intended to offset each other and allow the Company to originate a variable rate loan, while providing a contract for fixed interest payments for the customer. The net cash flow for the Company is equal to the interest income received from a variable rate loan originated with the customer. The fair value of these derivatives is based on a discounted cash flow approach. The fair value assets and liabilities of centrally cleared interest rate swaps are net of variation margin settled-to-market.
In March 2021, the Company terminated the last layer of interest rate swaps associated with available-for-sale agency mortgage-backed securities - residential, which resulted in swap termination payments to counterparties totaling $1.9 million. The corresponding fair value hedging adjustment was allocated pro-rata to the underlying hedged securities and is being amortized over the remaining lives of the designated securities. The Company had amortization expense totaling less than $0.1 million for both the three and nine months ended September 30, 2026 and 2025, which was recognized as a reduction to interest income on securities.
In June 2020, the Company terminated all fair value hedging relationships associated with loans, which resulted in swap termination payments to counterparties totaling $46.1 million. The corresponding loan fair value hedging adjustment as of the date of termination is being amortized over the remaining lives of the designated loans, which have a weighted average term to maturity of 8.3 years as of September 30, 2026. The Company had amortization expense totaling $0.9 million and $2.7 million for the three and nine months ended September 30, 2026, respectively, and $1.0 million and $2.7 million for the three and nine months ended September 30, 2025, respectively, related to these previously terminated fair value hedges which was recognized as a reduction to interest income on loans.
The following table presents the notional amount and fair value of interest rate swaps utilized by the Company at September 30, 2026 and December 31, 2025.
| September 30, 2026 | December 31, 2025 | |||
|---|---|---|---|---|
| (amounts in thousands) | NotionalAmount | FairValue | NotionalAmount | FairValue |
| Asset Derivatives | ||||
| Derivatives not designated as hedging instruments | ||||
| Back-to-back swaps | $17,507 | $460 | $45,050 | $210 |
| Total contracts | $17,507 | $460 | $45,050 | $210 |
| Liability Derivatives | ||||
| Derivatives not designated as hedging instruments | ||||
| Back-to-back swaps | $17,507 | $(460) | $45,050 | $(210) |
| Total contracts | $17,507 | $(460) | $45,050 | $(210) |
The fair value of interest rate swaps was estimated using a discounted cash flow method that incorporates current market interest rates as of the balance sheet date.
Back-to-back swaps consist oftwo interest-rate swaps (a customer swap and an offsetting counterparty swap). As a result of this offsetting relationship, no net gains or losses are recognized in income. The Company received $0.3 million of cash collateral from counterparties as security for their obligations related to these swap transactions at September 30, 2026. The Company received no cash collateral from counterparties as security for their obligations related to these swap transactions at December 31, 2025. The Company hadno cash pledged as collateral to counterparties as security for its obligations related to these agreements as of September 30, 2026. The Company pledged cash collateral of $0.3 million to counterparties as security for its obligations related to these agreements as of December 31, 2025.
Note 13: Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive loss, included in shareholders' equity, for the nine months ended September 30, 2026 and 2025, respectively, are presented in the table below.
| (amounts in thousands) | Unrealized Losses On Debt Securities | Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity | Total |
|---|---|---|---|
| Balance, January 1, 2026 | $(18,277) | $(1,853) | (20,130) |
| Other comprehensive loss before reclassifications from accumulated other comprehensive loss before tax | (19,711) | — | (19,711) |
| Reclassifications from accumulated other comprehensive loss to earnings before tax | — | 333 | 333 |
| Other comprehensive (loss) income before tax | (19,711) | 333 | (19,378) |
| Income tax (benefit) provision | (4,533) | 81 | (4,452) |
| Other comprehensive (loss) income - net of tax | (15,178) | 252 | (14,926) |
| Balance, September 30, 2026 | $(33,455) | $(1,601) | $(35,056) |
| Balance, January 1, 2025 | $(30,413) | $(2,240) | (32,653) |
| Other comprehensive income before reclassifications from accumulated other comprehensive loss before tax | 12,114 | — | 12,114 |
| Reclassifications from accumulated other comprehensive loss to earnings before tax | — | 432 | 432 |
| Other comprehensive income before tax | 12,114 | 432 | 12,546 |
| Income tax provision | 2,788 | 109 | 2,897 |
| Other comprehensive income - net of tax | 9,326 | 323 | 9,649 |
| Balance, September 30, 2025 | $(21,087) | $(1,917) | $(23,004) |
The components of accumulated other comprehensive loss, included in shareholders' equity, for the three months ended September 30, 2026 and 2025, respectively, are presented in the table below.
| (amounts in thousands) | Unrealized Losses On Debt Securities | Unrealized Losses On Debt Securities Transferred From Available-For-Sale To Held-To-Maturity | Total |
|---|---|---|---|
| Balance, July 1, 2026 | $(19,430) | $(1,687) | $(21,117) |
| Other comprehensive loss before reclassifications from accumulated other comprehensive loss before tax | (18,215) | — | (18,215) |
| Reclassifications from accumulated other comprehensive loss to earnings before tax | — | 113 | 113 |
| Other comprehensive (loss) income before tax | (18,215) | 113 | (18,102) |
| Income tax (benefit) provision | (4,190) | 27 | (4,163) |
| Other comprehensive (loss) income - net of tax | (14,025) | 86 | (13,939) |
| Balance, September 30, 2026 | $(33,455) | $(1,601) | $(35,056) |
| Balance, July 1, 2025 | $(24,514) | $(2,053) | $(26,567) |
| Other comprehensive income before reclassifications from accumulated other comprehensive loss before tax | 4,454 | — | 4,454 |
| Reclassifications from accumulated other comprehensive loss to earnings before tax | — | 180 | 180 |
| Other comprehensive income before tax | 4,454 | 180 | 4,634 |
| Income tax provision | 1,027 | 44 | 1,071 |
| Other comprehensive income - net of tax | 3,427 | 136 | 3,563 |
| Balance, September 30, 2025 | $(21,087) | $(1,917) | $(23,004) |
| (amounts in thousands) · Amounts Reclassified fromAccumulated Other Comprehensive Loss for the Three Months Ended · Amounts Reclassified fromAccumulated Other Comprehensive Loss for the Nine Months Ended | |||||
|---|---|---|---|---|---|
| Details About Accumulated Other Comprehensive Loss Components | September 30, 2026 | September 30, 2025 | September 30, 2026 | September 30, 2025 | Affected Line Item in the Statements of Operations |
| Reclassifications from accumulated other comprehensive loss to earnings before tax | $(113) | (180) | $(333) | $(432) | Interest Income |
| Total amount reclassified before tax | (113) | (180) | (333) | (432) | Income (loss) before income taxes |
| Tax benefit | (27) | (44) | (81) | (109) | Income tax provision (benefit) |
| Total reclassifications from accumulated other comprehensive loss | $(86) | $(136) | $(252) | $(323) | Net income (loss) |
Note 14: Segment Information
The Company operates as a single reportable segment, managing the business and assessing financial performance on a consolidated basis. While there are several lines of business within the operating segment, they are closely interrelated and cannot operate independently. Accordingly, the Chief Operating Decision Maker (“CODM”) evaluates operations and financial performance on a Company-wide basis and all of the Company’s operations are aggregated intoone reportable operating segment.
The CODM regularly receives and reviews the Company’s net income on a consolidated basis and uses key metrics to evaluate the overall performance of the Company and make decisions regarding the allocation of resources. Additionally, the CODM reviews budget-to-actual variances to analyze these profit measures as a single operating segment.
The function of the CODM is performed by the Finance Committee. This Committee consists of the highest level of management that is responsible for the Company’s overall resource allocation and performance. The Finance Committee includes the Chairman and Chief Executive Officer, President and Chief Operating Officer and Executive Vice President and Chief Financial Officer.
Note 15: Recent Accounting Pronouncements
Recently Adopted Accounting Standards
ASU 2023-09 -Income Taxes (Topic 740): Improvements to Income Tax Disclosures (December 2023)
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures. This ASU enhances the transparency and usefulness of income tax disclosures, which addresses investor requests for more transparency about income tax disclosures related primarily to the rate reconciliation and income taxes paid information. The Company adopted this guidance on January 1, 2025 and it did not have a material impact on its consolidated financial statements.
Newly Issued But Not Yet Effective Accounting Standards
ASU 2024-03-Income Statement-Reporting Comprehensive Income - Expense Disaggregations Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (November 2024)
In November 2024, the FASB issued ASU No. 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregations Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This ASU requires additional disclosures of the nature of expenses included in the Company’s income statement. The new standard requires disclosures about specific types of expenses included the income statement. The guidance is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.
ASU 2025-08 -Financial Instruments - Credit Losses (Topic 326) - Purchased Loans (November 2025)
In November 2025, the FASB issued ASU No. 2025-08, Financial Instruments - Credit Losses (Topic 326) - Purchased Loans. This ASU changes the accounting for certain acquired purchased seasoned loans ("PSL") by applying the gross‑up method, which records an allowance for expected credit losses at acquisition as an adjustment to amortized cost basis rather than a day one provision through earnings. The guidance is intended to simplify post‑acquisition accounting, reduce inconsistency between PCD and non-PCD loans, and eliminate day one credit loss expense for in‑scope PSLs. The amendments are effective for public business entities for annual periods beginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.
ASU 2025-09 -Derivatives and Hedging (Topic 815) - Hedge Accounting Improvements (November 2025)
In November 2025, the FASB issued ASU No. 2025-09 Derivatives and Hedging (Topic 815): Hedge Accounting Improvements. This ASU intends to better align hedge accounting with entities’ risk management activities. Key amendments include expanding the ability to group forecasted transactions with similar (rather than identical) risk exposure, establishing a model for hedging interest payments on choose‑your‑rate debt, expanding hedge accounting for certain forecasted nonfinancial transactions, and updating guidance on net written options and foreign‑currency‑denominated debt. The amendments are effective for public business entities for annual periods beginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.